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Abstract 
 
Lipid membranes are versatile tools for the spatial organization of biomolecules. On one 
hand, lipid vesicles represent enclosed compartments to maintain chemical environments and 
allow the efficient entrapment of substances. On the other hand, lateral inhomogeneous 
membranes provide the two dimensional sorting of membrane-bound compounds. In this 
work, lipophilic nucleic acids were used to build multicompartment systems based on lipid 
membranes by the controlled assembly of vesicles and the domain specific functionalization 
of inhomogeneous membranes. Three dimensional architectures of vesicles were formed by 
the sequential assembly of vesicles on layer-by-layer coated particles. Upon binding of the 
vesicles to the particles the vesicles remained stable – they did not fuse neither became leaky. 
Molecules could be entrapped inside the vesicles and released on demand. It was shown that 
the vesicles assembled on a particle can be transported to a defined destiny using an optical 
tweezer. Thus, the targeted delivery and the release of encapsulated molecules on site was 
achieved. It was also shown that vesicles immobilized on the particles can be fused by remote 
control, resulting in a mixing of membrane associated compounds. Different lipophilic 
nucleic acids were arranged in two dimensional patterns by incorporation into domain-
forming vesicles. Cholesterol-modified DNA revealed an equal distribution to both domains 
in liquid-liquid phase-separated membranes, whereas palmitoylated peptide nucleic acid 
partitioned into the liquid-ordered domain, which resembles lipid rafts of cellular membranes. 
Using the palmitoylated peptide nucleic acid and tocopherol-modified DNA both domains of 
liquid-liquid phase-separated vesicles were functionalized with different DNA recognitions 
sites. Both constructs could be mixed and separated by temperature control. 
 
Key words: Lipophilic nucleic acids, DNA, PNA, Lipid vesicles, Assembly 
 IV 
Zusammenfassung 
 
Lipidmembranen ermöglichen die räumliche Anordnung von Biomolekülen. Einerseits 
repräsentieren Lipidvesikel Kompartimente zur Aufrechterhaltung chemischer Milieus und 
dienen der Verkapselung verschiedenster Substanzen. Anderseits stellen inhomogene 
Membranen Matrizen für eine laterale Organisation von Membrankomponenten dar. In der 
vorliegenden Arbeit wurden lipophile Nukleinsäuren zum Aufbau kompartimentalisierter 
Strukturen auf der Basis von Lipidmembranen benutzt, erstens, für die geordnete, 
dreidimensionale Assemblierung von Vesikeln, zweitens, für eine spezifische 
Funktionalisierung inhomogener Lipidmembranen.  
Definierte Schichten stabiler Lipidvesikel wurden auf „layer-by-layer“ beschichteten 
Silikapartikeln angeordnet. Mit Hilfe einer optischen Pinzette wurde der gerichtete Transport 
der mit Vesikeln beschichteten Partikel demonstriert. Moleküle konnten in den Vesikeln 
verkapselt und bei Bedarf vor Ort freigesetzt werden. Zudem wurde die kontrollierte Fusion 
der immobilisierten Veskel gezeigt, die eine Durchmischung von verschiedenen 
Membrankomponenten zur Folge hatte.  
Lipophile Nukleinsäuren wurden in die Membranen von lipiddomänenbildenden Vesikeln 
inkorporiert. Cholesterolbasierte DNS verteilte sich hierbei homogen über die gesamte 
Membran. Palmitoylierte Peptid-Nukleinsäure konzentrierte sich hingegen in der flüssig-
geordneten Phase von flüssig-flüssig phasenseparierten Membranen, welche sogenannten 
Lipid Rafts in Zellmembranen ähnelt. Mittels der palmitoylierten Peptid-Nukleinsäure und 
tocopherolmodifizierter DNS wurden lateral inhomogene Membranen domänenspezifisch 
funktionalisiert. Beide Konstrukte konnten temperaturabhängig vermischt und separiert 
werden. 
Schlagwörter: Lipophile Nukleinsäuren, DNS, Peptid-Nukleinsäure, Lipidvesikel, Assemblierung 
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Abbreviations 
 
C6-NBD-PE 1-Palmitoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4 
 yl)amino]hexanoyl}-sn-glycero-3-phosphocholine 
CHO-K1 chinese hamster ovary cells 
Chol cholesterol 
chol_DNA1 cholesteryl-TEG-modified DNA; sequence: cholesteryl-TEG-5’- 
TCC GTC GTG CCT TAT TTC TGA TGT CCA-3’ 
chol_DNA1* cholesteryl-TEG-modified DNA; sequence: cholesteryl-TEG-5’- 
TCC GTC GTG CCT TAT TTC TTC (FAM)GA TGT CCA-3’ 
chol_DNA2 cholesteryl-TEG-modified DNA; sequence:  
5’- AGG CAC GAC GGA-3’-TEG-cholesteryl 
Cryo-tem Cryo electron microscopy 
DMEM Dulbecco's Modified Eagle Medium 
DNA deoxyribonucleic acid 
DNA1* DNA oligonucleotide; sequence:  
5’-FAM-TGG ACA TCA GAA ATA-3’ 
DNA2* DNA oligonucleotide; sequence: 5’-Rh-AAG GAG AAG AA-3’ 
DNA3* DNA oligonucleotide; sequence:  
5’-FITC-TGG ACA TCA GAA ATA-3’ 
DNA4* DNA oligonucleotide; sequence:  
5’-TAT TTC TGA TGT CCA-FITC-3’ 
DOPC 1,2-dioleoyl-sn-glycero-3-phosphocholine 
dsDNA double stranded DNA 
DTT dithiothreitol 
EDTA ethylenediaminetetraacetic acid 
ET energy transfer efficiency 
FAM carboxyfluorescein 
FBS fetal bovine serum 
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FITC fluoresceine isothiocyanate 
FLIM Fluorescence Lifetime Imaging Microscopy 
FRAP Fluorescence Recovery After Photobleaching 
FRET Förster Resonance Energy Transfer 
GPI glycosylphosphatidylinositol anchor 
GPI-mCFP fusion protein of mCFP with GPI anchor 
GPMV giant plasma membrane vesicle 
GUV giant unilamellar vesicle 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
IRF instrument response function 
LbL layer-by-layer 
LbL particles layer-by-layer coated particles 
ld liquid-disordered 
lo liquid-ordered 
LSM laser scanning microscope 
LUV large unilamellar vesicle 
mCFP monomeric cyan fluorescent protein 
N-NBD-PE 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2- 
1,3-benzoxadiazol-4-yl) 
NBD 7-benzylamino-4-nitrobenz-2-oxa-1,3-diazole moiety 
N-Rh-PE 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine  
rhodamine B sulfony)l 
palm_PNA palmitoylated PNA; sequence: 
Pal-Lys(Pal)-Gly-Glu2-Gly-ttcttctcctt-Glu2-Gly-CONH2 
PBS phosphate buffered saline 
PDADMAC poly(diallyldimethylammonium chloride) 
PMAA poly(methacrylic acid) 
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PMS plasma membrane sphere 
PNA peptide nucleic acid 
POPC 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine 
POPS 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine 
PS penicillin/streptomycin 
Rh lissamine rhodamine B (rhodamine) moiety 
RNA ribonucleic acid 
siRNA short interference RNA 
SM sphingomyeline 
SNARE soluble N-ethylmaleimide-sensitive factor attachment protein 
receptor 
ssDNA single stranded DNA 
SSM N-stearoyl-D-erythro-sphingosylphosphorylcholine 
TEG triethylene glycol 
Tm melting temperature of dsDNA 
tocopherol_A17 tocopherol-modified DNA; sequence: 
5’-LAA AAA ALA AAA AAA AAA AAA AAA A-3’ 
tocopherol_DNA1 tocopherol-modified DNA; sequence: 
5’-TLT TTT TLT TTT ATT TCT GAT GTC CA-3’ 
tocopherol_DNA2 tocopherol-modified DNA; sequence: 
5’-TGG ACA TCA GAA ATA TTT LTT TTT LT-3’ 
tocopherol_N16 tocopherol-modified DNA; sequence: 
5’-TLC CCC CLT TTT TGT CGC TTC AGC-3’ 
tocopherol_T18 tocopherol-modified DNA; sequence: 
5’-LTT TTT LTT TTT TTT TTT TTT TTT T-3’ 
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 1 
1 Introduction and Aim 
 
Compartmentalization on a nano- or micrometer scale is one of the crucial concepts of life. 
The organization of specific functions is often based on the use of lipid membranes. The 
concepts known from nature can be transferred into biotechnological approaches to build 
cargo carriers, nanoscopic reaction volumes, or enclosed chemical environments. To get an 
impression of the full potential of such lipid-based systems, one can take a view on the 
eukaryotic cell. The lipid membrane consists mainly of phospho, and sphingolipids, as well as 
cholesterol, and specific membrane proteins.[1] The spatial organization of the functional 
compounds is achieved by two different principles. First, lipid membranes of different 
architecture and composition constitute different compartments: e.g. cytosol, endosomes, 
Golgi apparatus, endoplasmatic reticulum, mitochondria, and nucleus. On one hand, the 
membrane represents a barrier separating different environments from each other. Many 
molecules cannot pass the membrane because of their hydrophilicity or their size. Thus, the 
compartments form enclosed volumes for the different cellular functions as storage of 
information, synthesis of biomolecules, or metabolic activities. On the other hand, the 
compartments stay in contact with each other: Signal transduction pathways are activated by 
docking of specific molecules to membrane anchored receptor proteins[2] and fusion of 
vesicles with membranes drives the delivery of molecules from one compartment to the 
other.[3] Second, membrane compounds are inhomogeneously organized in the membrane by 
a lateral and transversal sorting. For example, specific membrane proteins are segregated into 
lipid clusters known as lipid rafts (Figure 1) enriched in cholesterol, saturated lipids, and 
sphingolipids.[4] Although many questions concerning lipid rafts, like their size, stability, 
lifetime, or their biophysical properties, are not yet cleared,[5] many membrane proteins 
partition favorably to rafts,[6] and their biological functions depend on the partitioning 
behavior.[7] 
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Figure 1: Scheme of a lipid raft in the plasma membrane of a cell. Yellow: lipid rafts; blue: 
non-raft region. Modified image from[7]  
 
In this work, the two described principles for a spatial organization of functionalities – the 
formation of enclosed volumes and the lateral sorting mediated by lipid membranes - were 
explored for biotechnological approaches using lipid vesicles and lipophilic nucleic acids. 
 
1.1 Lipophilic nucleic acids 
 
Lipophilic nucleic acids are conjugates of DNA, RNA, or the artificial peptide nucleic acid 
(PNA) with a lipophilic moiety. Using specific properties of the nucleic acids, such constructs 
have already been applied in various biotechnological and biomedical approaches, e.g. for the 
delivery of short interference RNA (siRNA). During the past decade RNA interference via 
siRNA has found a great attention because of its potential for therapeutic applications. The 
main obstacle in vivo, concerning the delivery of the siRNA into the cells, is the low 
permeability of the plasma membrane for the siRNA. To overcome this problem, lipophilic 
modified siRNA has been shown to be useful.[8] The uptake and gene silencing can be further 
improved by altering the hydrophobic modification of the siRNA,[9,10] by incorporation of 
the lipophilic siRNA into high density lipoprotein particles before administration,[9] and by 
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introduction of a cleavage site between RNA and the lipophilic modification.[11,12] 
Alternatively, lipophilic PNA can be used. PNA consists of a pseudopeptide backbone that is 
modified with nucleosides. Figure 2 illustrates the structural differences between DNA and 
PNA. 
 
Figure 2: Backbones of DNA and PNA. Image taken from[13]  
  
PNA binds to complementary single stranded DNA (ssDNA) forming PNA/DNA duplexes 
via Watson-Crick base pairing, as well as to double stranded DNA (dsDNA) by a “strand 
invasion”. In contrary to RNA or DNA, PNA is not charged. The lack of electrostatic 
repulsion between PNA and DNA results in a high stability of PNA/DNA duplexes.[14] 
Moreover, PNA is more stable against degradation, as it is not cleavable by enzymes, neither 
by proteases nor by nucleases, and is more sensitive to single base pair mismatches.[15,16] 
Due to these specific properties of PNA, lipophilic PNA is a promising tool for the targeting 
of ssDNA and dsDNA. Incorporated into surfactant micelles, PNA has become a promising 
candidate for electrophoretic DNA separation.[17 2008] Many different conjugates of PNA 
with hydrophobic moieties, e.g. adamantyl residues,[18] fatty acids,[19] cholesterol,[20] and 
lipophilic cations,[21] have also been tested for gene silencing to enhance the low uptake of 
unmodified PNA into cells. Conjugations of triphenylphosphonium cations via a disulfide 
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bonding with the PNA has been shown to allow the uptake into the cytosol and block gene 
expression efficiently.[21] 
DNA, being more stable than RNA against hydrolysis and cheaper than PNA, is used for the 
functionalization of lipid membranes. Lipophilic DNA was found to insert into lipid 
membranes of cells,[22] vesicles of different size,[23,24,25,26,27,28,29] and supported 
bilayers,[25,30,31,32] retaining its ability to hybridize with complementary DNA strands. 
This allows functionalization of membranes with various molecules that are attached to the 
complementary DNA, as it was demonstrated with dye labeled oligonucleotides.[22,23,24,33] 
Beyond that, vesicle-vesicle adhesion can be mediated (Figure 3c, d)[27,34,35 2007,36,37,38] 
and liposomes can be immobilized on solid supports[25,32] or supported lipid 
bilayers.[35,36] Based on these properties of lipophilic DNA oligonucleotides, various 
biotechnological approaches have been explored. By the tethering of large unilamellar 
vesicles (LUVs) on a micro-patterned surface Städler et al. arranged vesicles precisely on a 
micrometer scale providing a method for the making of membrane-based micro arrays.[39] 
By attaching oligonucleotides to the surface of cells cell-cell adhesion could be triggered to 
form three-dimensional cell networks (Figure 3a, b).[40] 
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Figure 3: DNA mediated membrane adhesion. (a, b) cells connected by complementary DNA 
attached to the cell surfaces. (c) Assembly of giant unilamellar vesicles mediated by 
complementary lipophilic DNA. (d) Principle of DNA aggregation mediated by addition of 
DNA to vesicles with incorporated lipophilic DNA. Images modified from (a, b),[40] 
(c),[29,41] 
 
Furthermore, it is possible to mimic some functions of membrane proteins using lipophilic 
DNA. When two populations of vesicles carrying lipophilic nucleic acids with 
complementary sequences are mixed, two scenarios are conceivable: Either, upon 
hybridization both membranes are connected, but still kept in the distance that is given by the 
dsDNA. In this model the lipophilic DNA acts like a receptor that mediates membrane 
adhesion in cells (Figure 3).[34] Or, by bringing the membranes in a very close contact, 
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fusion of the membranes might be promoted in a “SNARE”-like way (SNARE: soluble N-
ethylmaleimide-sensitive factor attachment protein receptor) (Figure 4).[42 jacs,43] SNAREs 
are components in protein complexes that mediate membrane fusion in eukaryotic cells.[3] 
Thus, mixing of membrane compounds or the vesicles' content can be obtained.  
 
Figure 4: Fusion of lipid vesicles mediated by (a) SNAREs, (b) cholesterol-modified DNA. 
Image modified from [44] and [43] 
 
Therefore, lipophilic RNA, PNA, and DNA have the potential to facilitate the construction of 
lipid-based systems that mimic the structures found in nature. Lipid vesicles can serve as 
potential building blocks even for complex hierarchical structures. 
 
1.2 Lipid vesicles, polymersomes, and polymer capsules 
 
The production of vesicles is quite variable: Applying different methods, size and 
morphology can be altered, and the use of different lipids allows the tuning of the charge, 
rigidity of the lipid bilayers, temperature- and pH -sensitivity. As it is possible to encapsulate 
various types of molecules inside the vesicles, liposomes are used in cosmetic and 
pharmaceutical application as drug carriers. For instance, liposome systems are under 
development for coatings of contact lenses,[45] and as drug delivery systems for 
antibiotics,[46] and are already approved for cancer therapy.[47] In the latter cases the use of 
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liposomes improves the delivery to the tumor site, and reduces the toxicity of the drugs.[46] 
An active targeting can be achieved by surface modification with specific ligands.[47] 
Furthermore, the triggered release of the drug molecules in distinct environments is an 
important issue of recent research. Studies report on liposome formulations liberating 
encapsulated molecules in presence of phospholipases,[48] reductive environments,[49], and 
low pH.[50] Nanoreactors can also be build using lipid vesicles, e.g. by the encapsulation of 
enzymes. By external stimuli the enzymes can be released to catalyze a distinct reaction. 
Alternatively, when the substrate is able to pass the membrane barrier, the reaction can be 
catalyzed inside the vesicle. Till now, enzyme containing vesicles have found applications in 
the field of biomedicine and the cheese ripening process.[51]  
When lipid vesicles are described concerning their applicability for biotechnology, similar 
approaches based on polymers should not be excluded. The so-called polymersomes are 
vesicles consisting of amphiphilic block copolymers, that can be loaded with biomolecules, 
integral membrane proteins can be incorporated into the polymer membrane, and active 
enzymes can be entrapped inside the polymersomes.[52,53] This enables the positioning of 
different enzymes to separated sites: inside and outside the polymersome, as well as inside the 
polymer membrane. In this way, nanoreactors for cascade reactions were constructed (Figure 
5a).[54,55]  
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Figure 5: (a) Scheme of a polymersome used as a nanoreactor for a cascade reaction. 
Enzymes are placed inside, and outside the polymersome, as well as inside the membrane. 
Image modified from[54] (b) Formation of LbL capsules by the coating of a positively 
charged support. Image modified from[56] 
 
Another versatile approach to build micrometer sized capsules is the layer-by-layer (LbL) 
technology. By the step wise adsorption of several layers of oligomers or polymers, surfaces 
can be coated with a precise control of the coating’s thickness.[56] The adhesion of the layers 
can be mediated by diverse interactions, like electrostatic interactions, hydrogen bondings, 
DNA hybridization, sequential chemical reactions, metal–ligand complexation, or 
hydrophobic interactions.[56] For biotechnological applications bioactive substances, like 
nucleic acids,[57] peptides,[58] or even virus particles[59] can be incorporated inside the 
layers. When particles are coated by the LbL technique, capsules can be obtained by the 
dissolution of the core (Figure 5b).[56,60] The capsules can be filled, e.g. with DNA,[61,62] 
enzymes,[63] or antigens,[64] and the cargo by can released by remote control.[62] Thus, 
LbL-based capsules might find application as drug delivery systems or microreactors. 
 
1.3 Artificial multicompartment systems 
 
By the assembly of the described lipid or polymer based vesicles, multicompartment systems 
can be constructed – mimicking the compartments of eukaryotic cells. Different cargos can be 
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encapsulated into different containers for a co-delivery of active substances. Tuning the 
physical and chemical properties of the capsules' walls, the release rate of the different cargos 
can be controlled.[65] The Assembly of lipid vesicles is one possibility to reach that goal. 
This can be obtained by the use of lipophilic DNA, as described above,[27,29,37], other DNA 
mediated aggregation,[66] or avidin-biotin interactions.[67] Apart of that, vesicles can be 
entrapped within larger vesicles: For instance, Bolinger et al. invented a method for the 
loading of large unilamellar vesicles with small unilamellar vesicles without disturbing the 
vesicles integrity.[68] Molecules inside the small unilamellar vesicles stayed encapsulated 
until release into the larger vesicle was triggered by temperature change. This approach 
demonstrates the controlled separation and mixing of compounds on a nanometer scale. 
Comparable systems were produced using the ethanol-induced interdigitation of phospholipid 
bilayers. The resulting micrometer-sized “vesosomes” show separated lipid compartments 
inside an enveloping lipid bilayer (Figure 6a).[69] Due to the shielding of the outer 
membrane, the inner vesicles are protected from degradation, e.g. by phospholipases, and 
retain cargo molecules longer than unilamellar vesicles.[70] Therefore, vesosomes are more 
stable in a physiological environment making them suitable for biomedical application.  
Figure 6: (a) Freeze fracture tunnel electron microscopy images of a vesosome, a lipid-based 
multicompartment system, white bar corresponds to 0.4 µm;[69] (b, c) Fluorescence 
microscopy images of a microreactor consisting of five concentric compartments, before (b) 
and after (c) a cascade reaction, green and red fluorescence indicate different reaction 
products; bars correspond to 5 µm.[71] 
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Concentric capsules display another form of multicompartment systems. These onion-like 
structures are produced in a step wise manner by repeating several coating steps, including the 
precipitation of an inorganic support. After the formation of the layers, the support can be 
dissolved leaving the concentric compartments that are separated by polyelectrolyte 
layers[72] or matrices of biopolymers.[71] Figure 6b and c show such a system used as a 
nanoreactor for a cascade reaction.[71] Finally, different materials can be combined to obtain 
multicompartment systems. For instance, Städler et al. used solid LbL coated particles as a 
support for the immobilization of liposomes loaded with active enzymes.[73] The binding of 
the liposomes was mediated by hydrophobic interactions due to cholesterol moieties attached 
to the surface of the particles. Thus, several thousands of nanoreactors could be assembled on 
the solid support. 
In the above described examples, multicompartment systems were constructed by the 
assembly of different capsules or vesicles. An alternative is the use of particles bearing two 
sides of different chemistry or polarity, so-called Janus particles (Figure 7a).[74]  
Figure 7: Janus particles, (a) DIC and fluorescence microscopy image (insert) of polymer-
based Janus particles, one side containing magnetic nanoparticles (yellow), the other labeled 
with rhodamine (red), bars correspond to 100 µm;[75] (b) Fluorescence microscopy images of 
Janus particles based on polymersomes (size around tens of micrometers), domain formation 
was induced by addition of divalent cations.[76]  
 
These particles can be synthesized with various methods using materials like homopolymers, 
block copolymers, or silica particles.[77] The Janus particles can be amphiphilic when 
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hydrophilic and hydrophobic polymers are combined. Such particles could find use as solid 
surfactants.[78] Using two polymers carrying different charges, zwitterionic Janus particles 
were produced.[74] Both sides can also carry different functionalizations as magnetic 
particles, fluorophores,[75] or protein modifications like streptavidin.[79] Specific 
polymersomes also show a separation into distinct domains. For instance, Christian et al. 
reported on the generation of Janus assemblies made of polymersomes containing polyanionic 
amphiphiles (Figure 7b).[76] Here, the domain formation was driven by the addition of 
divalent cations that act as a crossbridge between the negatively charged side chains of the 
polymers. 
 
1.4 Constructing multicompartment systems with lipophilic 
nucleic acids 
 
As described above, the ability of many lipophilic nucleic acids to insert spontaneously into 
lipid membranes and to hybridize with complementary DNA opens the way to realize 
different biotechnological approaches. First, the lipophilic nucleic acids display receptors for 
complementary DNA, RNA, or conjugates of DNA or RNA with different molecules or 
nanocrystals, e.g. organic dyes,[80] quantum dots,[81] peptides,[82] or proteins.[80] The 
functionalization of the lipid membrane is limited only by the availability of the DNA or 
RNA conjugate and its potential to hybridize with the lipophilic nucleic acid. Second, 
different membranes can be linked when lipophilic nucleic acids with a complementary 
sequence are used.[22,26,28,29,30,35,36,39] Finally, lipid vesicles might be immobilized on a 
surface that exposes DNA complementary to the lipophilic nucleic acids inserted into the 
membrane.[83] Here, the described concepts will be applied to build multicompartment 
systems on a nano- and micrometer scale. A lateral inhomogeneous organization of lipophilic 
nucleic acids in heterogeneous lipid membranes might be achieved by a specific design of 
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their lipophilic anchors, whereas three dimensional architectures of lipid vesicles can be built 
on a solid support using lipophilic DNA. 
 
1.5 Assembly of vesicles on a solid support using lipophilic nucleic 
acids 
  
The assembly of lipid vesicles allows the formation of multicompartment systems in which 
different vesicles carry different functions. The vesicles can be arranged on demand, using for 
example biotin-antibody interactions,[84] biotin-avidin interactions,[67] or lipophilic 
DNA.[26,38] The use of lipophilic DNA has the advantage that it allows an alteration of the 
inter-vesicle distance, as well as the possibility to reverse the assembly by several external 
stimuli like a temperature change, the reduction of ionic strength, or enzymatic treatment.[28] 
The assembly of the lipid vesicles can be obtained by mixing two populations of vesicles that 
carry complementary lipophilic nucleic acids resulting in vesicle aggregates.[28,29] Although 
size and composition of the aggregates can be controlled to some extent, the aggregation 
process does not lead to a hierarchical architecture of liposomes that would provide a precise 
regulation of the stoichiometry and the defined spatial organization of the vesicles. Granéli et 
al.[85] solved this problem by assembling layers of vesicles on a solid support: The first layer 
of vesicles was immobilized on a planar DNA-modified surface by hybridization of 
cholesterol-tagged DNA incorporated into the vesicles' membrane with the DNA on the 
support. On that first layer additional 4 layers of vesicles could be assembled in a stepwise 
manner based on the hybridization of cholesterol-modified DNA conjugates inserted into the 
vesicles' membranes (Figure 8). 
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Figure 8: DNA mediated assembly of vesicles layers on a solid support. Modified from[85]  
 
For many approaches, however, like the transport of active molecules to a target, the assembly 
of vesicles has to be mobile. This is possibly given for the vesicle aggregates but not for the 
immobilization of layers of vesicles on a planar solid support. To solve this problem the 
concepts can be combined (see aim): By the assembly of multiple layers of vesicless on 
micrometer sized particles the formation of a rational designed vesicle architecture can be 
realized that might be used as a delivery vehicle for co-delivery of bioactive molecules. 
 
1.6 Lateral organization of lipophilic nucleic acids in model 
membrane systems 
 
For a lateral organization of lipophilic nucleic acids in lipid membranes, the membrane itself 
can function as a template. Indeed, lateral inhomogeneities in lipid membranes known as lipid 
domains or lipid rafts are observed in artificial membranes like supported lipid bilayers[86] 
and giant unilamellar vesicles (GUVs)[87] as well as in the plasma membrane of eukaryotic 
 14 
cells. Bilayers consisting of mixtures of lipids that differ in their phase transition temperature 
often show a phase-separation. In binary mixtures a solid-fluid   phase-separation can be 
observed (Figure 9c).[88]  
 
Figure 9: Phase-separation in lipid membrane. (a, b) scheme of lipid chain orientation in the 
liquid-ordered phase (a), shaded ovals represent cholesterol, and the liquid-disordered phase 
of a lipid membrane (b);[89] (c) fluorescence microscopy image of a liquid-solid phase-
separated GUV;[88] (d) fluorescence microscopy images of giant plasma membrane vesicles 
(GPMVs) showing phase-separation, vesicles are still attached to the cells.[90] White bars 
correspond to 10 (c) and 5 µm (d), respectively. 
 
In contrary to the liquid phase, the solid phase shows a long range order concerning the 
conformation of the lipid chains.[91] In lipid membranes made from ternary mixtures 
including a lipid with a low phase transition temperature and a lipid with a high transition 
temperature, cholesterol often triggers a liquid-liquid phase-separation into a liquid-ordered 
(lo, Figure 9a), and a liquid-disordered (ld, Figure 9b) phase.[89] In the lo domain the lipids 
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are more tightly packed. For instance, GUVs prepared from a 1:1:1 mixture of 
dioleylphosphatidylcholine (DOPC), sphingomyelin (SM), and cholesterol (Chol) show a 
liquid-liquid phase-separation resulting in micrometer-sized domains at room 
temperature.[89] Here, the lo phase is enriched in Chol and SM, whereas the ld domain 
mainly consist of DOPC. Concerning the high content of Chol and SM, the lo phase of the 
GUVs resembles lipid rafts.[92] For the visualization of the lo and the ld phase with 
fluorescence microscopy, several fluorescent lipid analogues have been described, that 
favorably partition into one lipid phase,[93] and, thus, act as domain markers. Domain-
separated GUVs can act as model membrane systems to investigate the lateral partitioning of 
membrane proteins in cellular membranes. The composition of the lipid membrane of the 
GUVs, however, is quite simple, and cannot simulate the complex lipid-protein and protein-
protein interactions in cellular membranes.[94] To this end, other model membrane systems 
were developed. Both giant plasma membrane vesicles (GPMVs)[90] and plasma membrane 
spheres (PMS)[95] are directly derived from the plasma membrane of eukaryotic cells, 
retaining lipid and membrane protein composition. In both systems a phase-separation into 
microscopic lo and ld phases can be triggerd by cooling (GPMVs, Figure 9d),[90] or by the 
clustering of typical raft markers (PMS).[95] By incorporating of lipophilic nucleic acids into 
the membrane of these model systems – phase-separated GUVs, GPMVs, and PMS – the 
lateral organization of the lipophilic nucleic acids could be achieved. To tune the phase 
partitioning behavior of the lipophilic nucleic acids, the chemical structure of the membrane 
anchor can be altered. Tocopherol modified DNA segregates to the ld phase of liquid-liquid 
phase-separated GUVs.[23] To address both domains, nucleic acids partitioning into the lo 
domain are demanded. Furthermore, targeting of lipid rafts with lipophilic nucleic acids could 
alter the uptake into cells as lipid rafts are involved in clathrin-independent endocytosis.[96] 
Beales and Vanderlick reported on the lateral partitioning of cholesterol-modified 
oligonucleotides in GUVs showing phase-separation.[97] The cholesterol-based DNA showed 
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segregation into the fluid phase of liquid-solid phase-separated GUVs, whereas the construct 
showed a 2:1 preference for the lo phase in liquid-liquid phase-separated GUVs consisting of 
DOPC, dipalmitoyl phosphatidylcholine, and Chol. Moreover, it is known that cholesterol is 
enriched in lipid rafts. Against this background, it is reasonable to assume that a cholesterol 
modification of lipophilic nucleic acids would drive the partitioning into lipid rafts or the lo 
phase of model membrane systems. The raft association of membrane proteins is, however, 
often dependent on the palmitoylation of the proteins.[98] Therefore, coupling of palmitoyl 
chains to nucleic acids might also be a possible modification to access rafts or lo domains of 
phase-separated membranes. 
In summary, liquid-liquid phase-separated vesicles might function as templates for the lateral 
organization of lipophilic nucleic acids. This would allow the formation of a two dimensional 
multicompartment system, where different compartments are addressable by sequence 
specific hybridization of DNA.  
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1.7 Aim 
 
Complex reaction pathways, e.g. signaling pathways in cells, require a strict spatial 
organization of functional entities. The separation of different compounds and chemical 
environments can be achieved using lipid membranes. Two principles might be applied to 
realize the spatial organization: The building of lipid vesicle assemblies and the lateral 
organization of membrane-bound compounds. In this work lipophilic nucleic acids should be 
used to realize both concepts. 
First, lipid vesicles can act as compartments, where different contents are entrapped in the 
lumen or the membrane of the vesicles. The assembly of these vesicles on a mobil support 
would result in a three dimensional architecture of functional units that can be transported to a 
defined destiny. Different molecules might be encapsulated into different vesicles and 
released on demand for the targeted delivery of bioactive molecules. Furthermore, by the 
triggered fusion of the assembled vesicles membrane compounds could be mixed to start 
specific reactions. 
Second, lateral inhomogeneous lipid membranes might act as a template for a two 
dimensional sorting of membrane compounds. Using lipophilic oligonucleotides that reveal a 
distinct partitioning behavior into lipid phases, lipid domains become addressable by DNA or 
DNA-conjugates. Until now, no lipophilic nucleic acids have been described that partition 
exclusively into the lo phase of liquid-liquid phase-separated lipid membranes. These 
molecules would not only provide a functionalization of lipid rafts in the membrane of 
eukaryotic cells. Incorporation of two different lipophilic nucleic acids partitioning into the ld 
and the lo domain of domain-forming vesicles would result in two-sided vesicles where both 
domains can be functionalized with a wide variety of molecules attached to the 
complementary DNA. 
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2 Materials and Methods 
 
2.1 Chemicals  
 
1-Palmitoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-3-
phosphocholine (C6-NBD-PC), 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(7-
nitro-2-1,3-benzoxadiazol-4-yl) (N-NBD-PE), 1,2-dipalmitoyl-sn-glycero-3-
phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (N-Rh-PE), 1-palmitoyl-2-oleoyl-
sn-glycero-3-phosphocholine (POPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine 
(POPS), 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), N-stearoyl-D-erythro-
sphingosylphosphorylcholine (SSM), and cholesterol (Chol) were obtained from Avanti Polar 
Lipids, Inc., (Alabaster, USA). Chloroform and KCl was purchased from Merck (Darmstadt, 
Germany). Neomycin, Sucrose, calcein, dithiothreitol (DTT), Sephadex G50 fine, Triton X-
100 and ethylenediaminetetraacetic acid (EDTA) was obtained from Sigma-Aldrich 
(Taufkirchen, Germany), 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid (HEPES) 
was obtained from Carl Roth GmbH + CO. KG (Karlsruhe, Germany), Dulbecco's Modified 
Eagle Medium (DMEM) and penicillin/streptomycin (PS) were from PAN (Aidenbach, 
Germany), fetal bovine serum (FBS) and Hoechst 33342 was from Invitrogen (Carlsbad, CA, 
USA). 
LbL coated particles were produced by Surflay Nanotec GmbH (Berlin, Germany). The 
particles consisted of a silica core (Ø = 4.3 µm) coated with 6 alternating layers of the 
positively charged poly(diallyldimethylammonium chloride) (PDADMAC) and the negatively 
charged poly(methacrylic acid) (PMAA) as described elsewhere.[99] The negatively charged 
last layer was modified by the covalent attachment of 5'-adenosine 21mers. 
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Nucleic acids 
DNA oligonucleotides were purchased from BioTeZ (Berlin, Germany) or from Eurogentec 
S.A. (Belgium), tocopherol-modified deoxyuridine was synthesized in the group of Prof. Dr. 
Jürgen Liebscher (department of chemistry, Humboldt University, Berlin ) as described 
elsewhere.[100] Cholesteryl-TEG-modified oligonucleotides and FAM-modified 
oligonucleotides were obtained from Eurogentec S.A. (Belgium). The palmitoylated PNA 
(palm_PNA) was synthesized as described elsewhere by solid phase synthesis by the groups 
of Prof. Dr. Jürgen Liebscher and Prof. Dr. Oliver Seitz (department of chemistry, Humboldt 
University, Berlin).[99] The oligonucleotides are listed in Table 1. The lipophilic anchors are 
presented in Figure 10. 
 
Table 1: All nucleic acids were based on DNA, except of palm_PNA that is based on PNA. 
DNA1*, and chol_DNA1* were labeled with the green fluorescent dye carboxyfluorescein 
(FAM), DNA3*, and DNA4* were labeled with the green fluorescent dye 
fluoresceinisothiocyanate (FITC), DNA2*, an adenosine 20mer, and a thymidine 20mer were 
labeled with the red fluorescent dye rhodamine (Rh). L indicates lipophilic modifications. 
 
Abbreviation Sequence lipophilic 
modification 
DNA1* 5’-FAM-TGG ACA TCA GAA ATA-3’ - 
DNA2* 5’-Rh-AAG GAG AAG AA-3’ - 
DNA3* 5’-FITC-TGG ACA TCA GAA ATA-3’ - 
DNA4* 5’-TAT TTC TGA TGT CCA-FITC-3’ - 
 5’-TTT TTT TTT TTT TTT TTT TT-Rh-3’ - 
 5’-AAA AAA AAA AAA AAA AAA AA-Rh-3’ - 
tocopherol_T18 5’-LTT TTT LTT TTT TTT TTT TTT TTT T-3’ tocopherol 
tocopherol_A17 5’-LAA AAA ALA AAA AAA AAA AAA  
AAA A-3’ 
tocopherol 
tocopherol_N16 5’-TLC CCC CLT TTT TGT CGC TTC AGC-3’ tocopherol 
tocopherol_DNA1 5’-TLT TTT TLT TTT ATT TCT GAT GTC CA-3’ tocopherol 
tocopherol_DNA2 5’-TGG ACA TCA GAA ATA TTT LTT TTT  
LT-3’ 
tocopherol 
chol_DNA1 5’-LTC CGT CGT GCC TTA TTT CTG ATG  
TCC A-3’ 
cholesteryl-TEG 
chol_DNA1* 5’-LTC CGT CGT GCC TTA TTT CTT 
 C(FAM)GA TGT CCA-3’ 
cholesteryl-TEG 
chol_DNA2 5’-AGG CAC GAC GGA L-3’ cholesteryl-TEG 
palm_PNA L-Lys(L)-Gly-Glu2-Gly-ttcttctcctt-Glu2-Gly- 
CONH2 
palmitoyl 
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Figure 10: Lipophilic anchors of lipophilic nucleic acids. (a) tocopherol-modified 
deoxyuridine, used for tocopherol_T18, tocopherol_A17, tocopherol_N16, 
tocopherol_DNA1, and tocopherol_DNA2. (b) TEG-cholesteryl anchor of chol_DNA1*, 
chol_DNA1, and chol_DNA2. (c) Double-palmitoylated lysine of palm_PNA. 
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2.2 Buffers 
 
1. GUV buffer contained 250 mM sucrose, 10 mM Hepes, pH 7.4. 
2. Glucose buffer contained 280 mM glucose, 10 mM HEPES, pH 7.4 
3. KCl buffer contained 100 mM KCl, 10 mM Hepes, pH 7.4.  
4. Sucrose buffer contained 176 mM sucrose, 10 mM HEPES, pH 7.4; optional 0.5 mM 
calcein and 1 mM EDTA was added.  
5. Phosphate buffered saline (PBS) without Ca2+ and Mg2+, pH 7.4, was obtained from 
PAA (Pasching, Austria).  
6. Calcein buffer was 70 mM calcein, 10 mM Hepes, 1 mM EDTA, pH 7.4, 230 mOsm. 
7. Calcein exchange buffer was 10 mM KCl, 50 mM citric acid, 1 mM EDTA, pH 7.4, 
230 mOsm.  
 
2.3 Large unilamellar vesicles (LUVs) 
 
LUVs were produced by extrusion.[101] 2 µmol POPC in about 1 ml CHCl3 was added to a 
round bottom flask. CHCl3 was removed at 40 °C at low pressure (~10 mbar) under constant 
rotation to obtain a homogeneous lipid film. Fluorescently labeled POPC vesicles were 
obtained by using lipid mixtures containing 0.1-1mol% N-NBD-PE or N-Rh-PE, or a mixture 
of both lipid analogues. Table 2 shows the compositions of fluorescently labeled LUVs. 
 
Table 2: Composition of fluorescently labeled LUVs 
 
Composition Used in Chapter 
1.0mol% N-NBD-PE, 99.0 mol% POPC 3.1.4, 3.1.7  
0.1mol% N-Rh-PE, 99.9 mol% POPC 3.1.4 
0.3mol% N-NBD-PE, 0.3mol% N-Rh-PE, 99.4 mol% 
POPC 
3.1.7  
0.6mol% N-NBD-PE, 0.6mol% N-Rh-PE, 98.8 mol% 
POPC 
3.1.7  
0.6mol% N-NBD-PE, 99.4 mol% POPC 3.1.7  
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After 30 min the flask was ventilated. The lipid film was suspended in 1 ml sucrose, KCl, or 
calcein buffer. The lipid suspension was transfered into a cryo tube. 5 freeze-thaw cycles were 
performed by shock freezing the samples in a dry ice/isopropanol mixture and thawing in a 
water bath (T = 50 °C) for 3-5 min. The lipid suspension was eleven times extruded using a 
mini extruder from Avanti Polar Lipids, Inc., (Alabaster, USA) with a polycarbonate filter 
(pore size 100 nm) resulting in LUVs with a mean diameter of 100 nm.[101] The LUVs were 
mixed with tocopherol-modified oligonucleotides (molar ratio lipid:oligonucleotide = 200:1). 
The samples were incubated overnight at 4 °C. To separate the LUVs from free lipophilic 
oligonucleotides and lipid aggregates, two different methods were applied:  
1. Sucrose loaded vesicles (1 ml) were diluted in KCl buffer (4 ml) and centrifugated for 
1 h at 100'000 g. The supernatant was removed and the pellet consisting of the vesicles 
with incorporated lipophilic oligonucleotides was resuspended with the isoosmotic 
KCl buffer (1 ml).[72] 
2. Vesicles suspended in KCl buffer or calcein buffer were separated from unbound 
lipophilic oligonucleotides and lipid aggregates by column centrifugation. To this end, 
the matrix (Sephadex G50 fine) was incubated with a buffer that was isoosmotic to the 
buffer used for the vesicles’ preparation for at least 30 min (LUVs prepared in KCl 
buffer: KCl buffer; LUVs prepared in calcein buffer: calcein exchange buffer). 1 ml 
columns (Qiagen, Hilden, Germany) were filled with the matrix. After 
precentrifugation of the columns for 2 min at 530 g, the samples were added and 
centrifugated for 3 min at 530 g. The eluate containing the vesicles was collected and 
the volume of the eluate was determined. To restore the sample volume before the 
centrifugation step, KCl buffer or calcein exchange buffer was added, respectively.  
 
Sucrose-loaded LUVs were used for the assembly of one to three layers of LUVs on LbL 
particles (Chapter 3.1.4), the release and fusion assays of immobilized LUVs on LbL particles 
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(Chapters 3.1.5, 3.1.7) except for the time resolved calcein release assay and for the assembly 
of LUVs for cryo electron microscopy (Chapter 3.1.3). Assembly of LUVs on LbL particles 
was reproduced using LUVs produced with KCl buffer showing that column centrifugation 
did not affect binding of the LUVs to the particles. Calcein-loaded LUVs were used for the 
time resolved calcein release assay (Chapters 3.1.5, 3.1.6). 
 
2.4 Coating of LbL particles with LUVs 
 
The LbL particles (5% (w/v) in water) were sonified in a bath sonifier for 20 min. The 
particles (2.5 µl) were mixed gently with tocopherol_T18 containing LUVs or 
tocopherol_A17 containing LUVs (30 µL, 2 mM total lipid) and KCl buffer (217 µl). When 
LUVs were filled with calcein buffer, calcein exchange buffer was used instead of KCl buffer. 
The suspension was incubated under constant motion using Labquake (Barnstead 
Thermolyne) for at least 1 h or overnight at 4 °C. To separate the coated LbL particles from 
unbound LUVs, KCl buffer (750 µl) was added and the mixture was centrifuged for 1 min at 
326 g. The supernatant was removed, the pellet containing the particles was resuspended in 
KCl buffer (1000 µl), mixed gently, and centrifuged again. Washing was repeated three times. 
After the last centrifugation step only 750 µl of the supernatant were removed to obtain a 
250 µl suspension of the coated LbL particles for microscopy or fluorescence spectroscopy. 
To build a second (or third) layer, 780 ml of the supernatant were removed and 
tocopherol_T18 containing LUVs or tocopherol_A17 containing LUVs (30 µl, 2 mM total 
lipidv concentration) were added, proceeding as described above.  
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2.5 Giant unilamellar vesicles (GUVs) 
 
Giant unilamellar vesicles (GUVs) were prepared by the electroformation method[102] in a 
titanium chamber.[103] A 100 nmol aliquot of pure lipids or a lipid mixture in chloroform 
was spotted onto a titanium plate and heated to 50 °C to remove the solvent. Traces of 
chloroform were removed under vacuum for at least 1 h. After sealing, the titanium chamber 
was filled with 1 ml of GUV buffer. An alternating electrical field of 10 Hz, rising from 0.02 
to 1.1 V in the first 30 min, was applied for at least 150 min, followed by 30 min of 4 Hz and 
1.3 V to detach the formed liposomes. The process was carried out at 50-60 °C when lipid 
mixtures including cholesterol and SSM were used. When incorporation of lipophilic PNA in 
POPC GUVs was investigated (Chapter 3.2.2) lipophilic PNA (as a dry powder) was added to 
the lipid film before addition of GUV buffer. 
The following lipids or lipid mixtures were used:  
• POPC 
• DOPC/SSM/Chol (1/1/1 molar ratios) 
• POPC/SSM/Chol (1/1/1 molar ratios) 
• DOPC/SSM/Chol/POPS (1/1/1/1 molar ratios).  
 
In lipid mixtures, 0.1 mol% N-Rh-PE or 0.5 mol% C6-NBD-PC was used as a marker for the 
liquid-disordered domains. A 20 µl portion of GUV solution was mixed with 80 µl of a 
microscopy buffer (see below) and 0.13 µl of 10 µM lipophilic oligonucleotides or PNA, and 
a stoichiometric amount of complementary DNA (lipophilic oligonucleotide to lipid molar 
ratio of 1:3000 or 1:300) and incubated at room temperature for 15 min (lipophilic DNA 
oligonucleotide) or 1 h (lipophilic PNA). As a microscopy buffer, glucose buffer, PBS, or 
mixtures of both with different ionic strengths was used. 
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2.6 Cell culture and giant plasma membrane vesicle (GPMV) 
preparation 
 
Chinese hamster ovary cells (CHO-K1) cells were grown in DMEM without phenol red and 
supplied with 2 mM L-glutamine, 10% FBS, and 5% PS (complete medium) and incubated at 
37 °C and 5% CO2. Some CHO-K1 cells used were stably transfected with GPI-mCFP, a 
fusion protein of the monomeric cyan fluorescent protein (mCFP) and a 
glycosylphosphatidylinositol anchor (GPI). Note, the mCFP carries A206K mutation, which 
abolishes the natural tendency of fluorescent proteins to dimerize.[104] These cells were 
cultured in DMEM complete supplied with 250 µg/ml neomycin. Cells were forced to 
produce giant plasma membrane vesicles (GPMVs) or "blebs" upon treatment with buffer 
containing dithiothreitol (DTT) and formaldehyde as previously described.[90,94] Briefly, 
almost confluent cells (T25 flask) were washed twice with PBS, then 1.5 ml of PBS 
containing 2 mM DTT and 25 mM formaldehyde were added and flasks were incubated at 37 
°C for 1 hour, under gentle shaking (60-80 cycles per minute). GPMVs detached from cells 
were then collected from the bottom of the flask and transferred into a conical glass tube 
where they were allowed to sediment at 4 °C for about 30 min. For microscopy 30 µl of 
GPMV suspension were incubated with lipophilic PNA and complementary DNA (both 1 µl, 
10 µM) at 4 °C for 30 minutes, CHO-K1 cells at 37 °C for 1 hour. Vesicles were imaged in 
ibidi-dishes (ibidi GmbH, München, Germany). Images of the equatorial plane of the blebs 
were taken at 4 °C and the temperature was controlled with a water circulating bath. 
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2.7 Confocal microscopy 
 
All images were taken using an Olympus Fluoview 1000 with a 60x oil immersion objective. 
Laser light was directed to sample and separated from emitted light with a dichroic mirror 
(DM 405/488/559/635). FITC (NBD, FAM) was excited with a 488 nm Argon laser, 
rhodamine with a laser diode at 559 nm. Green fluorescence (FITC, NBD, or FAM) was 
separated from red fluorescent light (rhodamine) with a dichroic long pass filter (SDM 560) 
reflecting light with a wavelength below 560 nm. FITC (NBD, FAM) fluorescence was 
recorded between 500 and 545 nm, rhodamine fluorescence was recorded between 570 and 
670 nm. To avoid crosstalk of FITC (NBD, FAM) fluorescence in the rhodamine channel and 
vice versa, sequential scanning mode was used. Here, the sample is excited successively with 
the 488 nm and the 559 nm lasers while the green and the red fluorescence is recorded only 
during excitation with the 488 nm and the 559 nm laser, respectively. Heating and cooling 
(Chapter 3.2.5) was achieved using a water circulating bath and a heating block (self-
construction) fitting ibidi μ-Slide VI (ibidi GmbH, München, Germany).  
 
2.8 Fluorescence Lifetime Imaging Microscopy (FLIM) 
 
Förster Resonance Energy Transfer (FRET) between NBD (Chapter 3.1.7) or FAM (Chapter 
3.2.1) as the fluorescence donor and rhodamine as the fluorescence acceptor was measured 
via Fluorescence Lifetime Imaging Microscopy (FLIM) of the donor fluorescence. Images 
were acquired using the time-resolved LSM Upgrade Kit from PicoQuant (Berlin, Germany) 
on the microscope. NBD and FAM were excited at 470 nm using a pulsed laser diode. The 
fluorescence was detected by a single photon avalanche photodiode with a 540±20 nm filter. 
Data were analyzed using the SymPhoTime software (PicoQuant).  
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Measurement of NBD lifetime 
NBD lifetimes were measured to estimate whether LUVs fuse upon binding to LbL particles, 
and upon addition of melittin (Chapter 4.1.7). To this end, NBD lifetimes were not fitted to a 
two exponential decay,[103] but only to a one exponential decay to compare the lifetimes 
qualitatively. FLIM pictures were accumulated for 90 s. NBD fluorescence lifetime was fitted 
to a mono exponential decay, by a “tail-fit”, meaning that only the part which was not 
affected by the instrument response function (IRF) was used for the fit. Goodness of the fits 
was judged by visual examination of the residuals. 
 
Measurement of FAM lifetime  
FLIM pictures were accumulated for 60 s. The best two-exponential fit to the averaged 
fluorescence decay curve as judged by visual examination of the residuals was used. Here, 
also, a tail-fit was performed. For the calculation of energy transfer efficiency (ET), the 
amplitude weighted average lifetime <τ> was used (Equation 1):[105] 
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where τ1 and τ2 are the first and second lifetime components and A1 and A2 are the 
corresponding amplitudes. ET was calculated using Equation 2:[105] 
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where <τD> is the amplitude weighted average fluorescence lifetime of the donor in the 
absence of an acceptor (lifetime of FAM without rhodamine (N-Rh-PE)) and <τDA> is the 
amplitude weighted average fluorescence lifetime of the donor in the presence of the acceptor. 
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2.9 Moving LbL particles with an optical tweezer and monitoring 
calcein release with fluorescence microscopy   
 
LbL particles were coated with one layer of POPC LUVs with incorporated tocopherol_T18. 
In order to monitor the transient release of encapsulated molecules the LUVs were loaded 
with calcein at a self-quenching concentration (70 mM). The coated particles were diluted in 
buffer, and the suspension was placed on a glass slide. The particles were arranged to a 
pattern using an optical tweezer by capturing single particles before sedimenting onto the 
surface of the glass slides, and dropping the particles at defined place. Particles already 
settling on the glass surface could not be moved, most likely due to van der Waals attractions 
between the lipid membranes and the glass surface. To manipulate micrometer scaled 
particles with an optical tweezer, the particles have to consist of a material that (i) is 
transparent for the trapping laser, and (ii) has a different refraction index as the surrounding 
medium. This is valid for the LbL particles that are based on silica and are suspended in an 
aqueous milieu. 
An optical trap implemented into an inverted Olympus IX70 microscope equipped with an 
100x oil immersion objective was used. The trapping laser was a Nd:YAG-Laser (TEM00,  
λ = 1064 nm). 
To monitor calcein release of LUVs immobilized on LbL particles, a Nikon fluorescence 
microscope equipped with a 60x oil immersion objective was used. The sample was excited 
with a xenon arc fluorescence lamp using a 470±20 nm excitation filter. The emitted calcein 
fluorescence was recorded from 500 to 550 nm with a CCD camera. To enhance the time 
resolution, the optical resolution was reduced to 16*16 binning. Thus, single particles 
appeared as green dots instead of green open circles (Figure 19) although only the surface was 
fluorescently labeled with LUVs containing calcein. Time resolution was 12.5 ms. To release 
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the calcein, melittin (solution in H2O, final concentration 0.18 µM) was cautiously added to 
the particles. 
 
2.10 Fluorescence spectroscopy 
 
Fluorescence of Hoechst 33342 (Chapter 3.1.2) and calcein (Chapter 3.1.5) was measured by 
fluorescence spectroscopy. The fluorescence spectra were acquired with a Fluoromax-4 
spectrofluorometer (Jobin Yvon) at 25 °C using quartz cuvettes from Hellma (Müllheim, 
Germany). For excitation a xenon arc-lamp was used. Spectra were recorded with a R928P 
photomultiplier tube under continuous stirring. Fluorescence spectra were corrected regarding 
to the intensity fluctuations of the xenon arc-lamp and the wavelength dependent detection 
efficiency of the photomultiplier tube. Baseline spectrum of KCl buffer was subtracted from 
the spectra.  
 
Fluorescence spectra of Hoechst 33342 
Hoechst 33342 is a minor groove binding fluorescent dye, that shows a strongly increased 
fluorescence in presence of dsDNA.[72] 
 
Sample preparation 
Sample (1): 2.5 μl LbL particles (10% (w/v)) were mixed with 6 μl tocopherol_T18 
containing LUVs (lipid concentration 1mM) in 1 ml KCl buffer. The suspension was shaken 
with a Labquake for 90 min at 25 °C. Afterwards 1 μl Hoechst 33342 (162 μM, solution in 
H2O) was added, and the suspension was incubated for 120 min under constant shaking. For 
fluorescence measurements 1 ml KCl buffer was added. For control measurements the 
following probes were incubated with Hoechst 33342 instead of LbL particles and 
tocopherol_T18 containing LUVs: (2) 6 μl tocopherol_T18 containing LUVs; (3) 6 μl LUVs 
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(no lipophilic oligonucleotide incorporated) with 2.5 μl LbL particles; (4) 6 μl LUVs (no 
lipophilic oligonucleotide incorporated); (5) 6 μl tocopherol_N16 containing LUVs with 
2.5 μl LbL-A21 particles; (6) 6 μl tocopherol_N16-LUVs; (7) 3 μl tocopherol_T18 (10 μM); 
(8) 3 μl tocopherol_N16 (10 μM); (9) 2.5 μl LbL particles; (10) only Hoechst 33342. 
Acquisition of fluorescence spectra: Hoechst 33342 was excited at 350 nm (slit 5 nm). 
Spectra were recorded from 360-550 nm (1 nm increment, 5 nm slit).  
 
Fluorescence spectra of calcein 
Samples were prepared according Chapter 2.3 and 2.4. 20 µl of LbL particles (0.4% (w/v)) 
coated with calcein loaded LUVs were mixed with 1 ml calcein exchange buffer. Time 
resolved calcein fluorescence was detected for 1800 s (1 s integration time, 1 s increment). 
Calcein was excited at 492 nm, emission was detected at 515 nm, slits were 1 nm both for 
excitation and emission. After about 3 min 5 µl melittin (3.5 µM) was added. When a constant 
fluorescence level was reached 10 µl Triton X-100 (10% (w/v)) was added.  
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2.11 Calculation of calcein release 
 
Calcein release from LUVs assembled on LbL particles (Chapter 3.1.5) was calculated from 
the calcein fluorescence intensity spectra (2.10). Calcein release R was calculated using 
Equation 3, assuming that no calcein is released before melittin addition according to the 
previous results:[72] 
  100
)(
0max
0 ⋅
−
−
=
FF
FtFR    (3) 
 R: release of calcein from immoblized LUVs in percent 
 F(t): calcein fluorescence at time t 
 F0: fluorescence at the beginning of the measurement 
 Fmax: maximal fluorescence after addition of Triton X-100 
 
To estimate the release of encapsulated calcein during the storage time, the calcein release R’ 
was calculated using Equation 4: 
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 R': release of calcein from immoblized LUVs (after one week storage) in percent 
 F'(t): calcein fluorescence at time t (after one week storage) 
 F'max: maximal fluorescence after addition of Triton X-100 (after one week storage) 
 F0: fluorescence at the beginning of the measurement (without storage) 
 Fmax: maximal fluorescence after addition of Triton X-100 (without storage) 
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2.12 Cryo electron microscopy (Cryo-TEM) 
 
Sample preparation  
Two different kinds of sucrose loaded LUVs were produced as described in Chapter 2.3 
(100% POPC, lipid concentration 2 mM): One sample with incorporated tocopherol_T18, the 
other with incorporated tocopherol_A17. LUVs were mixed at RT and incubated for at least 
2 h at 4 °C (ratio tocopherol_T18 containing LUVs:tocopherol_A17 containing LUVs = 2:1).  
 
Cryo-TEM preparation  
Droplets of the sample (5 μl) were applied to perforated (1.5 μm hole diameter) carbon film 
covered 200 mesh grids (R1/4 batch of Quantifoil Micro Tools GmbH, Jena, Germany), 
which had been hydrophilized before use by 60 s plasma treatment at 8 W in a BALTEC 
MED 020 device. The supernatant fluid was removed with a filter paper until an ultra thin 
layer of the sample solution was obtained spanning the holes of the carbon film. The samples 
were immediately vitrified by propelling the grids into liquid ethane at its freezing point 
(90 K) operating a guillotine-like plunging device.  
 
Cryo-TEM measurement  
The vitrified samples were subsequently transferred under liquid nitrogen into a Tecnai F20 
FEG transmission electron microscope (FEI Company, Oregon, USA) using the Gatan (Gatan 
Inc., California, USA) cryoholder and -stage (Model 626). Microscopy was carried out at 
94 K sample temperature using the microscopes low dose protocol at a calibrated primary 
magnification of 62,000Χ and an accelerating voltage of 160 kV (FEG-illumination). Images 
were recorded using an EAGLE 2k-CCD device (FEI Company, Oregon, USA) at full 2048 
by 2048 pixel size. The defocus was chosen in all cases to be 1.96 μm. Cryo-TEM preparation 
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and measurements were performed by Dr. Kai Ludwig and Dr. Christoph Böttcher (Institute 
of Chemistry and Biochemistry, Freie Universität Berlin). 
 34 
3 Results 
 
3.1 Assembly of lipid vesicles on LbL particles  
 
LUVs with incorporated lipophilic DNA oligonuleotides were assembled on a solid support 
via sequence specific hybridization (Figure 11). As a solid support LbL coated silica particles 
were chosen. To allow the binding of the LUVs onto the particles via DNA hybridization the 
LbL particles were covalently modified with DNA oligonucleotides. First, precursor 
experiments were performed to test whether (i) complementary DNA binds to the LbL 
particles, (ii) vesicles with incorporated complementary lipophilic nucleic acids bind to the 
LbL particles by the formation of double stranded DNA, and (iii) vesicles can be aggregated 
by sequence specific hybridization of complementary lipophilic DNA. It was then tested 
whether a rational architecture of several vesicle layers can be constructed on the LbL 
particles by a step wise coating procedure. Finally, biotechnological questions were 
addressed: Encapsulation of molecules inside vesicles assembled on LbL particles and their 
controlled release, positioning of the system with an optical tweezer, as well as the triggered 
fusion of assembled vesicles. 
 
Figure 11: Scheme, detail of the assembly of two layers of vesicles on the surface of an LbL 
particle by sequence specific DNA hybridization. 
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3.1.1 Sequence specific binding of DNA to LbL particles funtionalized with 
complementary DNA 
  
To immobilize vesicles on particles via DNA hybridization, their surface had to be 
functionalized with DNA. For that purpose LbL particles were used. The particles consisted 
of a silica core (Ø = 4.3 µm) coated with 6 alternating layers of the positively charged 
poly(diallyldimethylammonium chloride) (PDADMAC) and the negatively charged 
poly(methacrylic acid) (PMAA) as described elsewhere.[99] The negatively charged 
outermost layer was modified by covalent attachment of a 5'-adenosine 21mer.  
First, it was tested whether the adenosine 21mer on the outermost polyelectrolyte layer was 
accessible for hybridization of complementary DNA. Addition of the complementary 3'-
rhodamine thymidine 20mer resulted in rhodamine fluorescence (red) on the surface of the 
particles (Figure 12a and b). Note, in this experiment the LbL particles were labeled by the 
covalent attachment of the green fluorescence dye FITC to the outermost polyelectrolyte layer 
for a better visualization of the particles. As a negative control the particles were mixed with a 
non-complementary 3'-rhodamine adenosine 20mer. Here, no red fluorescence of rhodamine 
was observed on the particles' surface (Figure 12c and d). This proves that there was no 
unspecific binding of DNA to the LbL particles. 
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Figure 12: Confocal fluorescence microscopy images of LbL particles modified by the 
covalent attachment of an adenosine 21mer and the green fluorescent dye FITC to the 
outermost polyelectrolyte layer. Addition of a rhodamine labeled complementary 
oligonucleotide led to rhodamine fluorescence (red) on the particles’ surface (a, b). The 
absence of fluorescence after addition of a rhodamine labeled non-complementary 
oligonucleotide (c, d) proves that no unspecific binding of DNA to the particles took place. 
White bars correspond to 10 µm. 
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3.1.2 Attachment of LUVs with incorporated lipophilic oligonucleotides to 
LbL particles by sequence specific hybridization of complementary 
DNA 
 
To build several layers of vesicles on LbL particles via DNA hybridization, it is a prerequisite 
that vesicles with incorporated lipophilic oligonucleotides complementary to the DNA on the 
LbL particles bind to the LbL particles. For the immobilization and assembly on the LbL 
particles LUVs made from 1-palmitoyl-2-oleoyl-sn-glycerophosphocholine (POPC) produced 
by the extrusion method[101] were used: Because of their relatively small size 
(Ø~100 nm)[101] compared to the LbL particles (Ø = 4.3 µm), many vesicles can be 
assembled on the particles’ surface. Furthermore, LUVs show a narrow size distribution[72] 
and are already well described for pharmaceutical applications[46,47] and as 
nanoreactors.[51] The LUVs were functionalized by the incorporation of lipophilic DNA that 
had a complementary sequence to the DNA on the LbL particles. The lipophilic 
oligonucleotide consisted of a DNA oligonucleotide conjugated with two lipophilic, 
tocopherol-modified deoxyuridine moieties. It was already shown that such lipophilic 
oligonucleotides incorporate spontaneously and stably into lipid vesicles and hybridize 
sequence specifically with complementary DNA.[23,24] The following sequence was used: 
5’-LTT TTT LTT TTT TTT TTT TTT TTT T-3’ (tocopherol_T18, L corresponds to the 
tocopherol-modified deoxyuridine moiety). LUVs with incorporated tocopherol_T18 were 
incubated with LbL particles. Unbound LUVs were removed from the LbL particles by 
several washing steps.  
To elucidate whether the LUVs bind to the LbL particles via sequence specific hybridization, 
a minor groove binding fluorescent dye (Hoechst 33342) was added to the suspension, that 
shows a strongly increased fluorescence in presence of dsDNA.[72] It was already shown that 
hybridization of a lipophilic oligonucleotide incorporated into the membrane of GUVs with a 
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complementary DNA strand can be monitored using Hoechst 33342.[23] Thus, hybridization 
of the lipophilic oligonucleotides incorporated into the LUVs’ membrane with the adonesine 
21mer on the LbL particles should result in an increase of the fluorescence of Hoechst 33342. 
As negative controls the LbL particles were incubated with POPC LUVs without lipophilic 
oligonucleotides, and LUVs with an incorporated, non-complementary lipophilic 
oligonucleotide (sequence: 5’-TLC CCC CLT TTT TGT CGC TTC AGC-3’; abbreviation: 
tocopherol_N16; L corresponds to the to the tocopherol-modified deoxyuridine moiety). 
Furthermore, Hoechst 33342 fluorescence was measured in presence of tocopherol_T18 and 
tocopherol_N16, without LUVs and incorporated into LUVs, as well as in presence of the 
LbL particles without further additives.  
Fluorescence intensity of Hoechst 33342 is only remarkably enhanced when LbL particles 
and tocopherol_T18 containing LUVs were present (Table 3, sample 1) compared to the 
fluorescence of Hoechst 33342 in buffer (Table 3, sample 10) and to the fluorescence in other 
control samples (Table 3, samples 2-9). Therefore, it can be concluded that binding of 
tocopherol_T18 containing LUVs to LbL particles led to the formation of dsDNA between 
lipophilic DNA (tocopherol_T18) and the DNA adenosine 21mer covalently bound to the 
LbL particles’ surface. All samples containing the LbL particles with 4.3 µm diameter 
(samples 3, 5, 8, and 9) showed increased background fluorescence, very likely caused by 
light scattering. The slight increase of fluorescence in the samples containing LN16 is most 
probably due to possible hairpin formation of the oligonucleotide.  
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Table 3: Fluorescence maxima of Hoechst 33342 in the presence of LbL particles, LUVs, and 
different lipophilic oligonucleotides; tocopherol_N16 refers to a lipophilic oligonucleotide 
that is non-complementary to LbL particles (sequence: 5’-TLC CCC CLT TTT TGT CGC 
TTC AGC-3’; L refers to the lipophilic deoxyuridine moiety). Data represent the mean of two 
measurements (x1 and x2), displayed in counts per second (cps/105). Errors represent the 
deviation of the two measurements x1-x2.  
 
No. LbL particles LUVs Lipophilic oligonucleotide Fluorescence intensity (cps/105) 
1 + + tocopherol_T18 10.1±0.1 
2 - + tocopherol_T18 2.6±0.3 
3 + + - 5.3±0.3 
4 - + - 3.3±0.4 
5 + + tocopherol_N16 5.7±0.8 
6 - + tocopherol_N16 2.8±0.1 
7 - - tocopherol_T18 2.9±0.2 
8 - - tocopherol_N16 4.5±0.4 
9 + - - 5.2±0.2 
10 - - - 2.9±0.2 
 
3.1.3 Aggregation of LUVs by hybridization of complementary lipophilic 
oligonucleotides 
 
To allow the formation of a three dimensional architecture of LUVs on LbL particles by 
hybridization of complementary tocopherol-based oligonucleotides, these lipophilic 
oligonucleotides should be able to mediate sequence specific vesicle-vesicle interactions 
without disturbing the vesicles’ integrity. This was tested by mixing tocopherol_T18 
containing POPC LUVs and POPC LUVs carrying the complementary lipophilic DNA, 
tocopherol_A17 (sequence: 5’-LAA AAA ALA AAA AAA AAA AAA AAA A-3’; L 
corresponds to the to the tocopherol-modified deoxyuridine moiety). The samples were 
studied by transmission electron cryomicroscopy (Cryo-TEM). Figure 13a and c show large 
and densely packed assemblies of intact vesicles. Dark spots are visible, mainly localized at 
the membrane's surface (Figure 14b, arrows point to dark spots), that most likely originate 
from dsDNA. In contrast, when only one kind of vesicles (LUVs with incorporated 
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tocopherol_A17) was present, no aggregation was observed, the LUVs were loosely spread 
(Figure 13b, arrows point to single vesicles). Here, none of the dark spots were found (Figure 
14a). In conclusion, complementary tocopherol-modified oligonucleotides mediated the 
formation of LUV aggregates by sequence specific hybridization; the vesicles did not 
aggregate if only one lipophilic oligonucleotide was present. Furthermore, the microscopic 
studies show that the binding did not interfere with the stability of the LUVs. 
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Figure 13: Cryo-TEM images: Intact vesicles are attached to each other via DNA 
hybridization. Vitrified samples of a 2:1 mixture of tocopherol_T18 containing LUVs and 
tocopherol_A17 containing LUVs (a, c) and of tocopherol_A17-LUVs (b) spanning the 
1.5 µm holes of a perforated carbon film imaged by TEM. Bars correspond to 1 µm in (a) and 
(b) and 100 nm in (c). Whereas large assemblies of intact vesicles in the micrometer scale can 
be seen for the mixed sample in (a) and (c), see arrow in (a), only single unassembled vesicles 
(some marked by arrows) are found in (b). Cryo-TEM measurements were performed by Dr. 
Kai Ludwig and Dr. Christoph Böttcher (Institute of Chemistry and Biochemistry, Freie 
Universität Berlin). 
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Figure 14: Cryo-TEM images: (a) Image of one control vesicle carrying only single DNA 
strands and therefore no spots of high density. (b) Image of a vesicle in an aggregate from the 
mixed sample with double-stranded DNA. Dark sports of high density (some indicated by 
arrows) most probably originate from double stranded DNA. Bars correspond to 50 nm. Cryo-
TEM measurements were performed by Dr. Kai Ludwig and Dr. Christoph Böttcher (Institute 
of Chemistry and Biochemistry, Freie Universität Berlin). 
 
3.1.4 Assembly of several layers of LUVs on LbL particles by DNA 
hybridization  
 
It was aimed to assemble sequential layers of distinct vesicles on the LbL particles 
functionalized with the adenosine 21mer. First, the particles were coated with one layer of 
POPC LUVs. In order to fabricate a complete and homogeneous coating of vesicles on the 
LbL particles, it was necessary to add an excess of LUVs to the particles. To calculate the 
amount of LUVs that is needed to saturate the surface of a particle, it was assumed that all 
LUVs have a diameter of 100 nm, are not deformed upon binding to the particles, and are 
densely packed. According to this calculation, a fourfold excess of LUVs containing 
tocopherol_T18 was gently mixed with the LbL particles. Unbound LUVs were removed by 
washing. A second layer of vesicles with lipophilic oligonucleotides was assembled by 
repeating the above-mentioned procedure starting from the LbL particles coated with one 
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layer of vesicles carrying tocopherol_T18. For this purpose, LUVs with oligonucleotides 
complementary to that of the first layer, tocopherol_A17, were used. A third layer of LUVs, 
with tocopherol_T18, was assembled on the particles coated with two layers. To visualize the 
liposome layers, the LUVs contained fluorescent lipids, either 1,2-dipalmitoyl-sn-glycero-3-
phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (N-NBD-PE, green fluorescence) 
or 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) 
(N-Rh-PE, red fluorescence). 
Figure 15a shows the confocal fluorescence microscope image of LbL particles covered with 
an almost homogeneous layer of N-NBD-PE labeled vesicles with incorporated 
complementary oligonucleotides (tocopherol_T18). This demonstrates the DNA mediated 
binding of LUVs to the LbL particles. In the absence of lipophilic oligonucleotides, N-NBD-
PE labeled LUVs did not bind to the LbL particles (not shown). The occasional non-specific 
binding of N-NBD-PE labeled vesicles carrying the non-complementary tocopherol_A17 
oligonucleotides (Figure 15b) can be explained by defects of the outermost negatively 
charged polymer layer that led to exposure of the underlying positively charged polymer layer 
of the LbL particles. Figure 15c and 17e show LbL coated particles with 2 and 3 layers of 
LUVs, respectively. On the first layer of N-NBD-PE labeled vesicles (containing 
tocopherol_T18), a second layer of N-Rh-PE labeled LUVs containing the complementary 
tocopherol_A17 was assembled (Figure 15c). In a control experiment, N-Rh-PE labeled 
LUVs containing tocopherol_T18, that is non-complementary to the first layer, were added. 
In this case, no red fluorescence was observed (Figure 15d). When three layers of LUVs were 
built, the LUVs of the first layer (containing tocopherol_T18) were labeled with N-NBD-PE, 
the LUVs of the second layer (containing tocopherol_A17) were not labeled, and the LUVs of 
the third layer (containing again tocopherol_T18) were labeled with N-Rh-PE (Figure 15c). 
As a control measurement N-Rh-PE labeled vesicles containing tocopherol_A17 were added 
to the LbL particles yet coated with two vesicle layers (Figure 15f). Note, that some 
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rhodamine fluorescence was observed on the particles due to unspecific binding. Presumably, 
tocopherol_A17 can hybridize with tocopherol_T18 incorporated into the first layer of LUVs, 
indicating defects of the second layer that make oligonucleotides from the first layer 
accessible. Due to this unspecific binding more than three layers could not be assembled on 
the LbL particles by sequence specific hybridization (not shown). This can be certainly 
avoided by using another pair of lipophilic oligonucleotides with different sequences that are 
non-complementary to any previous layer.  
In summary, up to three layers of LUVs were assembled on LbL particles. It could be shown 
that the formation of the layers is mediated by the sequence specific hybridzation of 
complementary DNA.  
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Figure 15: Coating of the LbL particles with oligonucleotide-containing vesicles: a scheme 
(not to scale) of the sequential layer-on-layer coating with 100 nm LUVs and images of the 
4.3 µm particles obtained by differential interference contrast (DIC) and confocal 
fluorescence microscopy. The fluorescence originates from the lipid analogues N-NBD-PE 
(green) and N-Rh-PE (red) incorporated into LUVs that are attached to the LbL particles. Bars 
correspond to 5 µm. (a) One layer of tocopherol_T18 containing N-NBD-PE labeled LUVs. 
(b) Control for a nonspecific binding: addition of non-complementary tocopherol_A17 
containing N-NBD-PE labeled LUVs: no binding. (c) Two layers (the first layer: 
tocopherol_T18 containing N-NBD-PE labeled LUVs, the second layer: tocopherol_A17 
containing N-Rh-PE labeled LUVs). (d) Control addition of non-complementary 
tocopherol_T18 containing N-Rh-PE labeled LUVs: no binding. (e) Three layers (the first 
layer: tocopherol_T18 containing N-NBD-PE labeled LUVs, the second layer: unlabeled 
tocopherol_A17 containing LUVs, the third layer: tocopherol_T18 containing N-Rh-PE 
labeled LUVs). (f) Control addition of non-complementary tocopherol_A17 containing N-Rh-
PE labeled LUVs: some binding is observed. 
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3.1.5 Encapsulation and release of molecules entrapped in LUVs 
assembled on LbL particles  
 
LUVs are suitable vehicles for the encapsulation of water soluble molecules.[72] Thus, they 
can function as delivery vehicles for the entrapped molecule. This concept might be applied to 
LUVs assembled on LbL particles. However, it needs to be tested whether the LUVs remain 
stable upon attachment to the surface of the LbL particles, that is, they do not loose content. 
For instance, small vesicles are known to fuse spontaneously forming a supported lipid 
bilayer on charged surfaces such as glass, mica, or LbL layers.[106,107] Apart from this, it is 
desirable that the system allows a release of the molecules by an external trigger, as it was 
shown for unbound vesicles, e.g. by the addition of surfactants[108] or specific peptides,[109] 
or a temperature change.[110]  
To demonstrate that small molecules remain entrapped in the lumen of LUVs attached to LbL 
particles via DNA hybridization, LUVs with incorporated tocopherol_T18 containing calcein 
(0.5 mM), a small water soluble dye, were attached to the LbL particles. Calcein is often used 
at a high self-quenching concentration of about 50-70 mM[109] to monitor the increase in 
calcein fluorescence intensity due to dequenching via fluorescence spectroscopy, when the 
fluorophore is released. Here, calcein concentration was kept well below the self-quenching 
concentration to visualize the fluorophore still entrapped inside the LUVs by fluorescence 
microscopy. Indeed, confocal fluorescence microscopy reveals calcein fluorescence on the 
surface of the LbL particles (Figure 16a, b). The fluorescence intensity did not notably 
decrease for several hours proving the stability of the immobilized LUVs for small water 
soluble molecules. In order to trigger calcein release, melittin, an amphipatic membrane pore-
forming and fusogenic peptide from bee venom,[111] was used. Addition of melittin led to an 
immediate calcein leakage and loss of the fluorescence signal (Figure 16c, d). 
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Figure 16: LbL particles coated with calcein-loaded LUVs and triggered release of the 
content. (a, c) Confocal fluorescence microscopy and (b, d) DIC images of the LbL particles 
covered with a layer of calcein-loaded tocopherol_T18 containing LUVs before (a, b) and 
1 min after addition of an aqueous solution of melittin (c, d; final melittin concentration was 
3.5 µM). Bars correspond to 5 µm. Vesicles were prepared by Dr. Anna Arbuzova 
(Department of Biology, Humboldt University Berlin). 
 
Further, release kinetics and long term stability were investigated. To this end, calcein was 
entrapped at a self-quenching concentration of 70 mM inside LUVs, which were then 
incubated with tocopherol_T18. After binding of the LUVs to the LbL particles and 
subsequent removal of unbound LUVs, the time dependent calcein fluorescence intensity of 
the particle suspension was measured (Figure 17, black line). Fluorescence intensity remained 
constant until addition of 2 µM melittin. Addition of Triton-X100 to dissolve the LUVs 
revealed that melittin caused a complete release within 3 min. Figure 17 (red line) shows the 
calcein release from tocopherol_T18 containing LUVs bound to LbL particles after one week 
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of storage at 4 °C. Although LUVs still retained calcein, a loss of calcein from the vesicles of 
about 30% was detected. Melittin treatment (final concentration 2 µM) led again to an 
immediate increase of calcein fluorescence reaching a constant level after one minute. 
Subsequent Triton-X100 addition did not result in a further increase of the fluorescence 
intensity showing that the added amount of melittin was again sufficient for the complete 
release of calcein.  
Figure 17: Release kinetic of calcein from LUVs with incorporated tocopherol_T18 
immobilized on LbL particles. Release was measured directly after the preparation of the 
coated particles (black line) or after one week of storage at 4 °C (red line) by monitoring the 
calcein fluorescence.  
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3.1.6 Transport of LbL particles coated with LUVs using an optical tweezer 
and subsequent calcein release 
 
In the previous chapter it was shown that small water soluble molecules can be encapsulated 
and released by addition of melittin. In this chapter the targeted delivery of LbL particles 
coated with one layer of LUVs is reported, achieved by the combination of three different 
approaches: the encapsulation of molecules inside LUVs immobilized on the particles, the 
controlled transport to a selected destiny by an optical tweezer, and the triggered release of 
the molecules. 
LbL particles were coated with one layer of POPC LUVs with incorporated tocopherol_T18, 
loaded with calcein at a self-quenching concentration (70 mM). The release of calcein from 
the particles arranged in a pattern (“Smiley”) by an optical tweezer was monitored using 
fluorescence microscopy. Figure 18 illustrates the formation of the pattern. 
 
Figure 18: Scheme, positioning of LbL particles coated with one layer of LUVs with an 
optical tweezer. The particles are trapped in the focus of the trapping laser, moved to a certain 
destiny, and dropped by switching of the trapping laser. By repetition of these steps patterns 
of particles were built. 
 
Figure 19a shows the assembly of LbL particles coated with one layer of LUVs before the 
release of calcein in a false color representation. The green color indicates a relatively low 
fluorescence that arises from the self-quenched calcein. Melittin was added to the 
arrangement of particles (Figure 19c). The subsequent calcein release resulted in a rising 
fluorescence (yellow and red color, Figure 19d and e) in the region around the particles due to 
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dilution of calcein. Finally, the calcein was completely released and diffused out of the 
observation area. As a consequence fluorescence faded out and finally disappeared (Figure 
19f). 
 
 
Figure 19: Calcein release from LbL particles coated with one layer of LUVs containing 
tocopherol_T18 by melittin addition. Particles were arranged to a pattern (“Smiley”) using an 
optical tweezer. Schemes in the upper and lower left shows the position of the single particles 
and one coated particle, respectively. Fluorescence microscopy images are presented in false 
colors. The bar on the right side shows the correlation between the fluorescence intensity and 
the color representation. (a, b): before the melittin addition, low calcein fluorescence due to 
self quenching of the fluorophore; (c): directly after melittin addition, low fluorescence 
remains, calcein is not yet released; (d, e): during calcein release fluorescence rises; (f): the 
fluorescence is diappeared, calcein is completely released and diffused out of the observation 
area. Please note, optical resolution was reduced to enhance time resolution. Bars correspond 
to 10 µm. 
 
3.1.7 Induced fusion of vesicles assembled on LbL particles 
 
For specific (bio)technological application fusion of LUVs assembled on LbL particles might 
be desired. For instance, two different reactants could be entrapped into different LUVs. 
Fusion of the LUVs would result in mixing of the reactants and start the reaction. Therefore, it 
is necessary that LUVs do not fuse upon binding to the LbL particles and that fusion can be 
triggered on demand. Two different fusion assays based on Fluorescence Recovery After 
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Photobleaching (FRAP) and Förster Resonance Energy Transfer (FRET) were applied to 
investigate whether the tocopherol_T18 containing LUVs fuse upon binding to the LbL 
particles or it is possible to trigger such fusion.  
For the FRAP assay LbL particles were coated with one layer of POPC LUVs with 
incorporated tocopherol_T18 containing the green fluorescent lipid analogue N-NBD-PE. If 
the LUVs stay intact upon binding to the LbL particles, the diffusion of the incorporated N-
NBD-PE molecules will be restricted to the small areas of individual LUVs of about 100 nm, 
whereas the formation of µm-sized continuous lipid membranes by fusion of the LUVs would 
enable a free diffusion of the N-NBD-PE molecules. Figure 20a-c shows that N-NBD-PE 
diffusion is restricted: When a spot on an LbL particle coated with N-NBD-PE labeled LUVs 
was bleached, no recovery of the fluorescence at this spot was observed. However, after 
fusion of the LUVs by pre-incubation of the coated LbL particles with melittin, fluorescence 
recovery was observed, showing that the particles were then covered by a rather continuous 
lipid coat (Figure 20d-f).  
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Figure 20: Intact vesicles are stably bound to the LbL particles as demonstrated by FRAP 
experiments. The LbL particles coated with one layer of N-NBD-PE labeled LUVs before (a, 
d), directly after (b, e), as well as 18 s after (c, f) the bleaching pulse. Bleached areas are 
indicated with arrows. (a–c) In the absence of melittin no fluorescence recovery on the LbL 
particles coated with vesicles was observed. (d–f) After pre-incubation with melittin, 
fluorescence recovery was observed. Bars correspond to 5 µm. 
 
The results of the FRAP assay do not guarantee the complete absence of vesicle fusion: When 
only a few LUVs fuse in each fusion event, the resulting vesicles or membrane patches have a 
size below the optical resolution limit of the microscope. Therefore, another fusion assay, 
based on FRET was applied that is independent of the size of a potential fusion product. The 
fusion assay was performed using a modified protocol of Düzgüneş et al.[112] LbL particles 
were coated with one layer of a mixture of tocopherol_T18 containing LUVs made from 
POPC: One part of the LUVs was labeled with 0.6mol% N-NBD-PE and N-Rh-PE (0.6% 
NBD-Rh-LUVs), the other vesicles contained no fluorophore (ratio 0.6% NBD-Rh-LUVs: 
unlabeled LUVs was 1:2). In the fluorescently labeled vesicles N-NBD-PE acts as a FRET 
donor and N-Rh-PE as a FRET acceptor. As a consequence the fluorescence lifetime of N-
NBD-PE is reduced compared to N-NBD-PE in the absence of a FRET acceptor. When the 
fluorescently labeled LUVs fuse with the unlabeled ones, the dyes are diluted in the 
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membrane. The FRET efficiency is reduced which can be monitored by the raised 
fluorescence lifetime of N-NBD-PE. Therefore, the fusion of the LUVs can be measured by 
FLIM. For control measurements LbL particles were also coated with LUVs labeled with a) 
0.6mol% N-NBD-PE (0.6% NBD-LUVs), b) 0.6% N-NBD-PE and N-Rh-PE, and c) 0.3mol% 
N-NBD-PE and N-Rh-PE (0.3% NBD-Rh-LUVs). Table 4 summarizes the results of the 
FLIM measurements. 
 
Table 4: Fluorescence lifetimes of NBD measured by FLIM of LbL particles coated with one 
layer of LUVs. LUVs consisted of POPC and contained different amounts of N-NBD-PE as 
FRET donor, and N-Rh-PE as FRET acceptor. FLIM was measured in presence and absence 
of melittin. The data displays the mean of ten measurements. * Lifetime not measured. Errors 
represent the standard error. 
 
sample <τ>/ns  
(no addition of melittin) 
<τ>/ns  
(addition of melittin) 
Mixture 0.6% NBD-Rh-LUVs 
and unlabeled LUVs 
4.0 ± 0.2 5.1 ± 0.4 
0.6% NBD-LUVs 7.7 ± 0.4 * 
0.6% NBD-Rh-LUVs 4.0 ± 0.2 4.0 ± 0.2 
0.3% NBD-Rh-LUVs 4.8 ± 0.3 * 
 
The fluorescence lifetime of N-NBD-PE in vesicles containing 0.6 mol% N-NBD-PE (no N-
Rh-PE) attached to the LbL particles was ~ 7.7 ± 0.4 ns. The fluorescence lifetime became 
shorter due to FRET when N-Rh-PE was also incorporated into POPC LUVs: 4.0 ± 0.2 ns and 
4.8 ± 0.3 ns for 0.6%-NBD-Rh-LUVs and for 0.3%-NBD-Rh-LUVs, respectively. When a 
mixture of unlabeled LUVs and 0.6%-NBD-Rh-LUVs was attached to the LbL particles, the 
lifetime of N-NBD-PE was identical to that measured in the absence of unlabeled LUVs. This 
indicates that LUVs did not fuse spontaneously. When fusion between unlabeled and labeled 
vesicles was triggered by addition of melittin to these LbL particles, the distance between 
donor and acceptor increased leading to a reduction of FRET efficiency measured by the 
enhancement of NBD fluorescence lifetime from 4.0 ± 0.2 ns to 5.1 ± 0.4 ns. Addition of 
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melittin to the LbL particles coated with only one type of vesicles did not change NBD 
lifetime. Here vesicles of the same composition fused with each other, the average distance 
between donor and acceptor was not affected and consequently the lifetime remained 
constant. 
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3.2 Lateral organization of lipophilic nucleic acids in model 
membrane systems 
 
Two different lipophilic nucleic acids were investigated concerning their phase partitioning 
behavior in phase-separated lipid vesicles. In particular, it was of interest whether the 
constructs partition into the lo phase of liquid-liquid phase-separated membranes, and, thus, 
are possible candidates for targeting rafts in cellular membranes. First, cholesterol-based 
DNA, and second, palmitoylated PNA were incorporated into liquid-liquid phase-separated 
GUVs and GPMVs. Palmitoylated PNA was also tested for its partitioning behavior in 
GMPVs and its ability to incorporate into the plasma membrane of cells. Finally, using the 
lipophilic PNA and tocopherol-modified DNA, two-sided vesicles – Janus vesicle – were 
generated. 
 
3.2.1 Lateral organization of membrane-associated cholesterol-modified-
DNA  
 
To investigate the phase partitioning behavior of cholesterol-modified DNA, different 
cholesterol-based oligonucleotides were incorporated into the membranes of GUVs consisting 
of a mixture of 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), N-stearoyl-D-erythro-
sphingosylphosphorylcholine (SSM), and cholesterol (Chol; molar ratio 1:1:1). GUVs of this 
composition have been shown to form microscopically visible lo and ld domains.[89] To 
visualize domains, GUVs contained 0.1 mol% N-Rh-PE as a marker for ld domains.[93] The 
lipophilic oligonucleotides consisted of one cholesterol moiety connected to the DNA 
oligonucleotide via a triethylene glycol (TEG) linker. The following sequences were used: 
cholesteryl-TEG-5′-TCC GTC GTG CCT TAT TTC TGA TGT CCA-3′ (chol_DNA1); 
cholesteryl-TEG-5′-TCC GTC GTG CCT TAT TTC TTC (FAM)GA TGT CCA-3′ 
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(chol_DNA1*); 5′- AGG CAC GAC GGA-3′-TEG-cholesteryl (chol_DNA2); (FAM)- 5′-
TGG ACA TCA GAA ATA-3′ (DNA1*). chol_DNA1 and chol_DNA1* display a 
complementary sequence to chol_DNA2 and DNA1, respectively. To visualize the 
cholesterol-modified DNA at the membrane, chol_DNA1* and DNA1* were labeled with the 
green fluorescent dye carboxyfluorescein (FAM). Figure 21 illustrates the constructs that 
were incorporated into GUV membrane: chol_DNA1* (a), a hybrid of chol_DNA1* and 
chol_DNA2 (b), as well as a hybrid of chol_DNA1 , chol_DNA2, and DNA1* (c). 
Figure 21: Scheme of cholesterol-based oligonucleotides incorporated into GUV membranes. 
DNA oligonucleotides are connected to the cholesterol moiety via a TEG linker. (a): 
chol_DNA1* (black); (b): hybrid of chol_DNA1* and chol_DNA2 (light grey); (c): hybrid of 
chol_DNA1 (black), chol_DNA2, and DNA1* (dark grey). The green star represents the 
FAM-label. 
 
As seen in Figure 22 for the chol_DNA1/chol_DNA2/DNA1* complex, the oligonucleotides 
were equally distributed to the lo and ld domains. FLIM measurements revealed differences 
between fluorescence lifetimes of FAM-labeled oligonucleotides in the lo and ld domains 
(Table 5). The slightly lower FAM fluorescence and the shorter fluorescence lifetime of FAM 
 57 
in the ld domain are due to FRET between the FAM and rhodamine (Rh). After correction of 
the intensities, no significant difference between the lateral distribution of the single 
cholesteryl-TEG-DNA (chol_DNA1*) and hybrids of two complementary cholesteryl-TEG-
DNAs (chol_DNA1*/chol_DNA2 or chol_DNA1/chol_DNA2/DNA1*) was observed 
(Table 5). The decreasing FRET efficiency in the order from chol_DNA1* to 
chol_DNA1*/chol_DNA2 and to chol_DNA1/chol_DNA2/DNA1* (Table 5) is consistent 
with the increasing distance between the FAM label on the oligonucleotides and the acceptor 
Rh in the membrane, due to the formation of a rigid DNA duplex.  
 
 
Figure 22: Confocal fluorescence microscopy images of GUVs consisting of DOPC, SSM, 
and Chol with incorporated chol_DNA1/chol_DNA2/DNA1* hybrid labeled with the green 
fluorescence dye FAM (a). As a marker for the ld phase the red fluorescent lipid analogue N-
Rh-PE was used (b). (c) shows an overlay of both images. The white bars correspond to 
50 µm. 
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Table 5: Results of FLIM measurements of FAM labeled cholesterol-based oligonucleotides 
incorporated into GUV membranes and the fraction partitioning into the lo phase. <τDA>: 
Average lifetime of FAM in the ld phase (FRET acceptor Rh present). <τD>: Average lifetime 
of FAM in the lo phase (FRET acceptor Rh absent). ET: Energy transfer between FAM and 
Rh due to FRET. fo: Fraction of the lipophilic oligonucleotides in the lo phase. Errors 
represent the standard error.  
 
oligonucleotides <τDA>/ns <τD>/ns  ET (FAM-
Rh) 
fo 
chol_DNA1* 3.39±0.04 4.05±0.03 0.16±0.01 0.48±0.06 
chol_DNA1*/chol_DNA2 3.36±0.11  3.83±0.04 0.12±0.03 0.50±0.05  
chol_DNA1/chol_DNA2/DNA1* 3.66±0.03 3.96±0.03 0.08±0.02 0.47±0.03 
 
To test whether the partitioning behavior can be altered by electrostatic repulsion 1-palmitoyl-
2-oleoyl-sn-glycero-3-phospho-L-serine (POPS) was incorporated into the membrane. POPS, 
as a lipid with one unsaturated chain, is localized preferentially in ld domains. In PBS buffer, 
the incorporation of POPS into the lipid mixture (1/1/1/1 DOPC/POPS/SSM/Chol) did not 
affect the lateral distribution of lipophilic oligonucleotides, either for chol_DNA1* or for 
chol_DNA1/chol_DNA2/DNA1* (chol_DNA1/chol_DNA2 not tested).  The incorporation 
and lateral distribution of chol_DNA1* in POPS-containing GUVs was also tested at lower 
ionic strengths. In sucrose buffer (250 mM sucrose, 10 mM Hepes) chol_DNA1* did not 
incorporate into the lipid membrane, most likely due to electrostatic repulsion. In buffers with 
higher ionic strength (mixtures of PBS and sucrose buffer), chol_DNA1* incorporated into 
negatively charged GUVs and was equally distributed between lo and ld phase, the same as in 
the zwitterionic membranes.  
Independent of the number of cholesterol anchors, cholesterol-modified DNA partitioned 
equally into the lo and the ld phase of DOPC/SSM/Chol and DOPC/POPS/SSM/Chol GUVs. 
The presence of negatively charged headgroups in the ld phase had no influence on the lateral 
partitioning behavior.  
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3.2.2 Incorporation of palmitoylated PNA into phospholipid membranes 
and hybridization with complementary DNA 
 
For the functionalization of lipid membranes with PNA, double palmitoylated PNA 
(palm_PNA) with the following sequence was used: Pal-Lys(Pal)-Gly-Glu2-Gly-ttcttctcctt-
Glu2-Gly-CONH2. Four glutamat residues were introduced to enhance the solubilty in an 
aqueous milieu. To test whether palm_PNA incorporates into lipid membranes and is 
accessible for the hybridization to complementary DNA, GUVs were prepared from a mixture 
of POPC and palm_PNA (molar ratio lipid:palm_PNA = 300:1). After incubation with a 
stoichiometric amount of the complementary strand 5´-Rh-AAG GAG AAG AA-3´ 
(DNA2*), GUVs’ membrane showed a bright red Rh fluorescence (Figure 23a, b), indicating 
that palm_PNA was inserted in the lipid membrane and hybridized with the complementary 
DNA. In a control measurement the palm_PNA containing GUVs were mixed with a non-
complementary Rh-labeled DNA. Here, no fluorescence on the vesicles was observed, 
proving that no unspecific binding of DNA occurred. Thus, these experiments revealed the 
sequence specific binding of the complementary DNA to palm_PNA inserted into the lipid 
membrane. 
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c d
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Figure 23: Confocal fluorescence images (a, c) and differential interference contrast images 
(b, d) of GUVs with incorporated palm_PNA. Addition of the complementary DNA labeled 
with Rh results in a red fluorescence on the GUV membrane (a, b). Non-complementary Rh-
labeled DNA did not bind to GUV surface (c, d). Bars correspond to 10 µm. 
 
3.2.3 Palmitoylated PNA for the targeting of lipid rafts 
 
Palm_PNA was investigated for a possible targeting to lipid rafts in the plasma membrane of 
eukaryotic cells. First, insertion of palm_PNA hybridized with the Rh-labeled, 
complementary oligonucleotide DNA2* into the membrane of Chinese hamster ovary (CHO-
K1) cells was studied. Palm_PNA was premixed with a stoichiometric amount of DNA2*, 
and added to the cells. Confocal and differential interference contrast images of CHO-K1 
cells after incubation with palm_PNA/DNA2* hybrids are shown in Figure 24a and 24b. Rh 
fluorescence was mainly localized to the plasma membrane, indicating that the 
palm_PNA/DNA2* hybrids were inserted into the plasma membrane. Some uptake of the 
membrane-incorporated palm_ PNA/DNA2* hybrids into endocytic vesicles was found 
(Figure 24a). In a control experiment, palm_PNA was premixed with a non-complementary 
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Rh-labeled oligonucleotide and added to CHO-K1 cells. No fluorescence was observed either 
at the plasma membrane or inside the cells (Figure 24c and 24d). These results show that 
palm_PNA (i) inserts into the cell plasma membrane, (ii) hybridizes specifically with the 
complementary DNA2*, and (iii) the inserted palm_PNA/ DNA2* hybrids could be taken up 
by endocytosis. The inhomogeneous distribution of rhodamine fluorescence on the cell 
surface might be due to lateral segregation of palm_PNA/DNA2* in rafts or accumulation in 
early endocytic vesicles. 
 
 
Figure 24: Palmitoyl-anchored PNA incorporates into the plasma membrane of CHO-K1 
cells. A confocal fluorescence microscopy image (a; b: differential interference contrast 
image) shows the localization of a complementary Rh-labeled oligonucleotide complementary 
to the palm_PNA. In contrast, a non-complementary Rh labeled oligonucleotide did not bind 
to palm_PNA and no fluorescence could be detected at the cell membrane (c; d: differential 
interference contrast image). Bars correspond to 10 μm. Cartoon (middle) summarizes the 
observations (grey rectangles: Chol). Cells were provided by Dr. Silvia Scolari (Department 
of Biology, Humboldt University Berlin). 
 
As lipid rafts have a size below the resolution limit of conventional fluorescence microscopes, 
the partitioning behavior of palm_PNA was studied two in model membrane systems showing 
phase-separation where the lo domain mimics lipid rafts:  
i. GUVs made from a 1:1:1 mixture of DOPC, SSM, and Chol 
ii. GPMVs, derived from the plasma membrane of CHO-K1 cells 
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The GUVs were labeled with the green fluorescent lipid analogue 1-palmitoyl-2-{6-[(7-nitro-
2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-3-phosphocholine (C6-NBD-PC) that 
preferentially segregates into the ld phase,[72] to distinguish between the lo and ld phase. 
Hybrids of palm_PNA and DNA2* were incorporated in the vesicles at a lipid to 
palm_PNA/DNA2* molar ratio of 300:1 or 3000:1. Figure 25a-c shows a typical domain-
forming vesicle with inserted palm_PNA/DNA2* hybrids at 3000:1 molar ratio. Green 
fluorescence from C6-NBD-PC (Figure 25a) visualizes the ld domain, whereas the red 
fluorescence from Rh on the hybrid palm_PNA/DNA2* was observed in the domain that 
could not be labeled with C6-NBD-PC (Figure 25b). This suggests that palm_PNA is almost 
exclusively localized in the lo domain as sketched in Figure 25 (see also overlay in Figure 
25c). An increase of the palm_PNA/DNA2*:lipid ratio to 1:300 did not change the 
partitioning behavior of the palm_PNA/DNAc2* hybrid (data not shown). To exclude the 
possibility of C6-NBD-PC influencing the palm_PNA/DNA2* partitioning, domain-forming 
vesicles lacking C6-NBD-PC were also prepared. As judged from the distribution of 
rhodamine fluorescence, almost all palm_PNA/DNAc2* hybrids were segregated into one 
domain (not shown), i.e. into the lo phase when taken into account the results with C6-NBD-
PC-labeled vesicles.  
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Figure 25: Lateral distribution of the palmitoyl-anchored PNA/DNA hybrid in the domain-
forming GUVs made of 1:1:1 DOPC/SSM/Chol (molar ratio palm_PNA:lipid = 1:3000). The 
panels show confocal fluorescence microscopy images of (a) C6-NBD-PC fluorescence 
visualizing the ld phase, (b) the membrane-inserted palm_PNA/DNA2* hybrids, which are 
localized in the lo phase of the GUV, and (c) an overlay of the images shown in (a) and (b). 
Bars correspond to 5 μm. Cartoon summarizes the observations: C6-NBD-PC is localized to 
the ld domain (light green), while palm_PNA/DNA2* (rose) is recruited to the cholesterol 
enriched lo domain (grey rectangles: Chol). 
 
GPMVs were derived from CHO-K1 cells stably expressing a fluorescent raft marker, a 
fusion protein of a glycosylphosphatidylinositol (GPI) anchor and monomeric cyan 
fluorescent protein (GPI-mCFP). GPI anchored proteins are known to partition into 
cholesterol-enriched domains in the plasma membrane of cells.[72] At low temperatures, a 
significant fraction of GPMVs showed phase-separation into micrometer-scaled lo and ld 
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domains.[90] As in the experiments with GUVs, hybrids of palm_PNA and DNA2* were 
incorporated into the vesicles. Palm_PNA/DNA2* co-localized with GPI-mCFP in the phase-
separated GPMVs at 4 °C. Therefore, it can be concluded that it partitioned into lo phase 
(Figure 26). 
 
 
Figure 26: Segregation of palm_PNA/DNA2* in domain-forming GPMVs at 4 °C. As a 
marker for the lo phase the fusion protein GPI-mCFP was used (a). Rh fluorescence of 
palm_PNA/DNA2* hybrid is co-localized with GPI-mCFP (b) in the lo phase. Bars 
correspond to 5 µm. GPMVs were provided by Dr. Silvia Scolari (Department of Biology, 
Humboldt University Berlin). 
 
The hybrids of palmitoylated PNA and complementary DNA2* segregated into the lo phase 
of both GUVs and GPMVs. As palm_PNA also inserts into the plasma membrane of cells, it 
is also likely that the palmitoylated PNA targets lipid rafts. 
 
3.2.4 Construction of Janus vesicles using palmitoylated PNA and 
tocopherol-based DNA 
 
The specific partitioning behavior of palm_PNA to segregate into the lo phase of model 
membrane systems opened the way to construct two-sided vesicles that exhibit different DNA 
sequences in different domains – Janus vesicles. For that aim GUVs and GPMVs that show a 
liquid-liquid phase-separation were functionalized with palm_PNA/DNA2* and the hybrid of 
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a tocopherol-modified DNA oligonucleotide and a complementary DNA strand. Tocopherol-
based oligonucleotides are known to partition into the ld phase of GUVs consisting of a 
DOPC/SM/Chol mixture.[23,24] For the tocopherol-modified oligonucleotide a construct 
with the following sequence was used: 5´-TLT TTT TLT TTT ATT TCT GAT GTC CA-3´ 
(tocopherol_DNA1), where L refers to a tocopherol-modified deoxyuridine. The 
complementary DNA (DNA3*; sequence: 5´-FITC-TGG ACA TCA GAA ATA-3´) was 
labeled with the green fluorescent dye fluorescein isothiocyanate (FITC) to visualize the 
tocopherol_DNA1/DNA3* hybrid inside the membrane. Figure 27a-c shows a phase-
separated GUV consisting of 1:1:1 mixture of DOPC, SSM, and Chol with incorporated 
palm_PNA/DNA2* and tocopherol_DNA1/DNA3* hybrids. Tocopherol_DNA/DNA3* 
(Figure 27a, FITC fluorescence) and the palm_PNA/DNA2* (Figure 27b, Rh fluorescence) 
partitioned into well separated domains, the ld and the lo domain, respectively. Figure 27c 
shows an overlay of both images, whereas Figure 27d represents a three dimensional overlay 
of the FITC and the Rh channel of another GUV. 
Using GPMVs derived from CHO_K1 cells two different types of vesicles where observed: 
(i) in vesicles presenting no domain-separation green fluorescence of 
tocopherol_DNA/DNA3* and red fluorescence of palm_PNA/DNA2* were spread over the 
whole membrane (not shown); (ii) in vesicles showing domain formation 
tocopherol_DNA/DNA3* (Figure 27e) and palm_PNA/DNA2* (Figure 27f) partitioned into 
different domains. Figure 27g shows an overlay of both images.  
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Figure 27: Lateral distribution of hybrids of palmitoyl-modified PNA with complementary 
DNA (palm_PNA/DNA2*) and tocopherol-modified DNA with complementary DNA 
(tocopherol_DNA/DNA3*) in domain-forming GUVs made from a 1:1:1 mixture of DOPC, 
SSM, and Chol (a-d) and GPMVs prepared from CHO-K1 cells (e-g). (a) FITC channel – the 
membrane-inserted hybrids tocopherol_DNA1/DNA3* are localized in the ld domain of a 
GUV. (b) Rh channel – the membrane inserted hybrids palm_PNA/DNA2* are localized in 
the lo domain. (c) Overlay of the images shown in (a) and (b). (d) The three-dimensional 
overlay of the confocal images of another domain-forming GUV. (e-g): In domain-forming 
GPMVs tocopherol_DNA/DNA3* (e) partitioned into another domain than 
palm_PNA/DNA2* (f). (g) Overlay of the images shown in (e) and (f) Bars represent 5 μm 
(a-c) and 10 μm (d-g). Cartoon (left, top) illustrates the results: palm_PNA/DNA2* (red) is 
recruited to the lo domain (rose; grey rectangles: Chol), while tocopherol_DNA/DNA3* to 
the ld domain (light green). GPMVs were provided by Dr. Silvia Scolari (Department of 
Biology, Humboldt University Berlin). 
 
3.2.5 Temperature-controlled mixing and separation of lipophilic nucleic 
acids in Janus vesicles 
 
In the above presented Janus vesicles two different membrane-incorporated compounds are 
separated by their partitioning into different lipid domains. When domain-forming vesicles 
are heated above the phase-separation temperature, the domains vanish resulting in a 
homogeneous membrane. This phenomenon was used to mix and separate both lipophilic 
nucleic acids – palmitoylated PNA and tocopherol-modified DNA. For the phase-separated 
vesicles GUVs were used, made from a 1:1:1 mixture of POPC, SSM, and Chol. This lipid 
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mixture was chosen because of its lower liquid-liquid phase transition temperature compared 
to DOPC/SSM/Chol membranes,[89] that is below the melting temperature of the amphiphilic 
PNA/DNA and DNA/DNA hybrids. 
Figure 28 shows a sequence of fluorescence images of a vesicle with incorporated 
tocopherol_DNA2/DNA4* (sequence: tocopherol_DNA2: 5´-TGG ACA TCA GAA ATA 
TTT LTT TTT LT-3´; DNA4*: 5´-TAT TTC TGA TGT CCA-FITC-3; L cossreponds to the 
tocopherol-modified deoxyuridine moiety) (a-d) and palm_PNA/DNA2* (e-h). At 
temperatures below phase transition both lo and ld phases were present and the constructs 
partitioned into different domains (Figure 28a and 28e). Upon heating above phase transition 
temperature, the two domains merged causing co-localization of tocopherol_DNA2/DNA4* 
(Figure 28b) and palm_PNA/DNA2* (Figure 28f) hybrids in the entire vesicle. Subsequent 
cooling led to reformation of several small lo and ld domains and separation of lipophilic 
DNA and PNA molecules (Figure 28c, 28g). The small domains tend to fuse minimizing the 
line tension until again only one lo and one ld domain remained containing 
tocopherol_DNA2/DNA4* and palm_PNA/DNA2* (Figure 28d, 28h). Thus, by heating and 
cooling of Janus vesicles with two different lipophilic nucleic acids incorporated into 
separated domains, controlled mixing and separation was achieved.  
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Figure 28: Mixing/demixing of tocopherol_DNA2/DNA4* (a-d) and palm_PNA/DNA2* (e-
h) hybrids incorporated in POPC/SSM/Chol GUVs due to temperature increase and decrease. 
Below phase transition temperature tocopherol_DNA2/DNA4* (a) and palm_PNA/DNA2* 
(e) are located to different domains (~5 °C). Above the phase transition temperature domains 
disappeared and both constructs mix (b, f) (~55 °C). After cooling (~46 °C) new smaller 
domains are formed (c, g), which then merge to larger domains separating again both types of 
constructs (d, h). Bars correspond to 10 μm. Scheme (top) illustrates the process: left – 
lipophilic DNA/DNA (green) and PNA/DNA (red) hybrids are separated to different domains 
(ld – light green, lo – rose) at low temperatures (corresponding to a and e); middle – upon 
heating, the whole membrane is in an ld state and both constructs intermix (as in b and f); 
right – subsequent cooling leads to a two-sided vesicle with lipophilic DNA and PNA 
partitioning into opposing sites (as in d and h). 
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4 Discussion 
 
In this work, lipid membranes were functionalized using three different kinds of lipophilic 
nucleic acids – tocopherol- and cholesterol-modified DNA, as well as palmitoylated PNA – to 
build organized structures on a micro- and nanometer scale: (i) a rational architecture of 
vesicle complexes, and (ii) the switchable lateral sorting of lipophilic nucleic acids in 
membranes. 
 
4.1 Controlled assembly of LUVs on a solid support 
 
It was shown that distinct layers of intact lipid vesicles can be built on a solid support given 
by LbL particles (Figure 29). The formation of the layers was achieved by sequence 
hybridization of tocopherol-modified DNA oligonucleotides. Up to three layers of different 
vesicles were formed as indicated by a different fluorescence labeling of the layers.  
 
 
Figure 29: Two layers of vesicles assembled on an LbL particle, scheme and microscopic 
images: red rhodamine fluorescence of the second layer (left), differential interference 
contrast image (middle), and green NBD fluorescence of the first layer (right). 
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When particles, already coated with three vesicle layers, were mixed with vesicles containing 
lipophilic nucleic acids complementary to those of the last vesicle layer, a binding to the 
particles was observed. Nevertheless, vesicles with incorporated non-complementary 
lipophilic DNA to the third layer – but complementary to the second layer – did also bind to 
these particles. This unspecific binding most probably originates from binding of the vesicles 
to the second layer, indicating that defects in the third layer were present. To overcome this 
problem other sequences for the lipophilic nucleic acids could be used, that are non-
complementary to any of the previous layers. 
The stability, with which the vesicles are attached to the solid support (first vesicle layer), or 
to other vesicles (second and third layer), is given by the stability of the dsDNA, and the 
anchoring of the lipophilic DNA molecules in the vesicle membrane. The stability of dsDNA 
can be characterized by the melting temperature (Tm) of the dsDNA. It has been shown that 
Tm values and melting profiles of dsDNA attached to nanoparticles,[113] or lipid vesicles[34] 
are different to dsDNA free in solution. For instance, DNA linked gold nanoparticles that are 
assembled by the hybridization of complementary DNA show an enhanced Tm and a sharp 
melting profile of the dsDNA compared to unmodified DNA. In these aggregates, many 
factors influence the Tm, like the particle size, the inter-particle distances, and the surface 
density of DNA on the nanoparticles.[113] To estimate the thermal stability of the dsDNA 
formed upon building of vesicle layers on the LbL particles several aspects have to be 
considered: (i) The reduced entropy of single stranded DNA when attached to the LbL 
particle, or of the lipophilic DNA when inserted into the lipid membrane of a vesicle, (ii) the 
cost of entropy for a vesicle upon tethering to the LbL particle, or another vesicle, (iii) 
electrostatic repulsion between dsDNA and the negatively charged surface of the LbL 
particles, (iv) electrostatic repulsion between different dsDNAs that are crowded in the 
tethering area, (v) reduced lateral mobility of the lipophilic DNA upon dsDNA formation with 
DNA immobilized on the LbL particles, (vi) inter-vesicle, and vesicle-particle 
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interactions.[34] Beales and Vanderlick measured the Tm of dsDNA of complementary 
cholesterol-modified DNA (10mers) incorporated into the membrane of LUVs. [34] They 
showed that the thermal stability of the vesicle aggregates was determined by Tm of the 
cholesterol-based DNA. Dependent on the concentration of the lipophilic oligonucleotides the 
Tm was about 15-20 °C enhanced compared to unmodified DNA free in solution. Thus, the 
lipophilic 10mers had a Tm of about 45-60 °C (unmodified DNA: ~ 30-40 °C). This can be 
explained by the reduced impact of entropy when two lipophilic DNA molecules that are 
already inserted into lipid membranes hybridize. In contrast, using lipophilic nucleic acids 
with different membrane anchors for vesicle aggregation showed Tm values comparable to 
those unmodified DNA.[38] Furthermore, duplexes of tocopherol-based DNA incorporated 
into vesicles and complementary unmodified DNA revealed a slightly lower Tm as dsDNA of 
unmodified DNA strands.[24] Therefore, Tm of the dsDNA formed upon binding of the 
vesicles to the LbL particles, or to other vesicles, might be in the range of Tm of unmodified 
DNA, or – considering entropic effects – slightly higher. The formation of vesicle layers on 
LbL particles was based on the hybridization of adenosine and thymidine oligomers. When a 
first layer of vesicles binds to the LbL particles, a duplex is built between an adenosine 21mer 
and tocopherol_T18. Here, the dsDNA has a maximal length of 18 base pairs, as 
tocopherol_T18 provides only the 18 thymidines for double strand formation (Dr. Andreas 
Bunge, Prof. Dr. Daniel Huster, personal communication). The double strand formation 
between the vesicle layers is mediated by hybridization of tocopherol_T18 and 
tocopherol_A17, with a maximal length of the dsDNA of 17 base pairs. Tm of dsDNA formed 
of unmodified adenosine 17mers and thymidine 17mers was calculated to 38.4°C (DNA 
concentration 250 nM, 100 mM NaCl; IDT oligo analyzer; 
http://www.idtdna.com/analyzer/Applications/OligoAnalyzer). If that value represented the 
real Tm of the dsDNA formed upon binding of the vesicles to the LbL particles or to other 
vesicles, the assembly of the vesicles would be stable at room temperature, but melting would 
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occur to some extent at physiological temperatures. For an enhanced thermal stability longer 
or mixed DNA strands containing guanosine and cytidine should be used for the 
oligonucleotides attached to the LbL particles and the lipophilic DNA. Shorter DNA 
sequences would not only destabilize the assembly but could also promote vesicle fusion due 
to a decreased inter-vesicle distance (see below).[28]  
The other prerequisite for a stable assembly of vesicles on LbL particles is the firm anchoring 
of the lipophilic oligonulceotides inside the lipid membranes. Due to the amphiphilic 
character of tocopherol-modified oligonucleotides these molecules can be solved in aqueous 
solutions. This finding suggests that in presence of lipid vesicles an equilibrium exists 
between tocopherol-based DNA in the aqueous solution and inserted into the membrane, 
although it is assumed that only a small portion is not bound to the vesicles. For cholesterol-
modified DNA it was shown that the anchoring of the lipophilic oligonucleotides is reversible 
when only one lipophilic anchor is present.[114] When two cholesterol moieties anchored the 
oligonulceotides to the membrane an irreversible insertion into the lipid bilayer was 
observed.[114]  
In this study sequential layers of LUVs were bound to LbL particles by the sequence specific 
hybridization of complementary tocopherol-based DNA, whereas a reorganization of the 
vesicles caused by a redistribution of the lipophilic oligonucleotides from one vesicle to 
another would have resulted in unspecific binding of vesicles. As this was not observed in a 
significant amount for the first two vesicle layers it can be assumed that such a redistribution 
of lipophilic oligonucleotides does not often take place. A stable tethering of the vesicles 
against shear forces is also provided. During the washing steps the particles coated with 
vesicles were resuspended using a pipette. The strong shear forces appearing at the tip of the 
pipette did not perturb the assembly of the vesicles. When the particles coated with one layer 
of vesicles (labeled with N-NBD-PE) were mixed with an excess with N-Rh-PE labeled 
vesicles, the N-Rh-PE labeled vesicles did bind to the LbL particles (see Figure 15d). This 
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observation indicates that the vesicles are tethered not only by one but by several dsDNA 
strands formed between lipophilic DNA and DNA attached to the LbL particles. The 
replacement of already immobilized vesicles could be achieved, however, when the coated 
particles (coated with N-NBD-PE labeled vesicles) were mixed with an excess of vesicles 
(labeled with N-Rh-PE labeled) by vigorous shaking (“vortexing”). Here, the shear forces 
were too strong, the vesicles were pulled out of the assembly, and binding places for new 
vesicles were free. 
One important question of this study was, whether LUVs neither loose their content nor fuse 
upon binding to the particles. Applying different methods it was shown that LUVs retained 
entrapped molecules and fusion did not happen. These methods complement each other: 
Cryo-TEM measurements clearly showed that vesicles did not fuse upon DNA directed 
aggregation, as it was also demonstrated for the LUVs bound to the LbL particles with the 
FLIM and FRAP experiments. In addition, calcein self-quenching assays not only showed that 
molecules stayed entrapped when the vesicles bound to the LbL particles, but also confirmed 
that no fusion process took place: It is known that lipid vesicles often show a transient leakage 
upon fusion.[48] Thus, the absence of any spontaneous calcein release strongly indicates that 
LUVs did not fuse upon binding to the particles. At first sight, this phenomenon seems quite 
surprising: Membranes tend to fuse when brought in close proximity,[28] and vesicles often 
rupture on solid supports forming supported lipid bilayers.[107] Indeed, Stengel et al.,[42] 
and Chan et al.[43] recently reported on vesicle fusion mediated by DNA in a SNARE-like 
manner, where lipophilic oligonucleotides triggered a close membrane-membrane contact. 
This was achieved by using oligonucleotides that carry the lipophilic modification on the 3'- 
and 5'-end of the DNA (Figure 30a).  
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Figure 30: Membrane-membrane adhesion caused by lipophilic nucleic acids. (a) When one 
lipophilic anchors is situated at the 3'-end, and the other at the 5'-end fusion is triggered in a 
SNARE-like way. (b) When both lipohilic nucleic acids are lipophilic modified at the 3' or the 
5'-end, the membranes are kept in distance. Modified scheme from [34] 
 
When both anchors are situated at the 3’- or the 5’-ends, the membranes are separated (Figure 
30b). When short sequences were used, however, fusion was also observed:[28] Vesicles 
aggregated with complementary lipophilic DNA 12mers showed vesicle fusion within 24 h, 
whereas DNA 24mers did not promote fusion. This can be explained by the increased 
distance between aggregated vesicles. In the case of the lipophilic nucleic acids used in this 
work (tocopherol_T18 and tocopherol_A17), the distance between connected membranes is 
17 base pairs, and no fusion was observed. Assuming that the complementary lipophilic 
nucleic acids form duplexes of a B-DNA conformation, the distance between the membranes 
was at least 5.8 nm. According to our results, this is enough to separate membranes and 
prevent fusion. The stability of the LUVs upon immobilization on LbL particles is most 
probably caused by electrostatic repulsion of the oligonucleotides on the vesicles' surface and 
the stiff double helix forming between the tocopherol_T18 containing LUVs and LbL 
particles or tocopherol_A17 containing LUVs. After one week storage at 4°C, however, the 
LUVs lost about 30% of the cargo. This is comparable to the loss from POPC LUVs free in 
solution, within the same time.(unpublished results) Using other lipid mixtures, e.g. including 
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cholesterol, it should be possible to minimize this loss, as it is known that cholesterol 
stabilizes lipid membranes.[115]  
It was shown that particles can be arranged to a pre-defined pattern using an optical tweezer. 
Thus, reservoirs with bioactive molecules can be organized on a micrometer scale. For 
example, in tissue regeneration, cell growth could be directed by loading the vesicles 
assembled on the particles with growth factors and nutrients. The arrangement of particles 
coated with vesicles could also be fixed by embedding the particles into a matrix, e.g. gels or 
polymers, for the building of micro-patterned coatings (Figure 31). Such films would sense 
changes in the chemical micro-environment and respond releasing distinct molecules just at 
the defined place. 
 
 
Figure 31: Formation of micro-patterned films. (a) Positioning of LbL particles coated with 
vesicles on a surface. (b) The arrangement is fixed by the embedding of the particles in gels or 
polymers. Function of single particles can be activated by remote control, or local changes in 
the chemical environment (red arrow). 
 
For biotechnological applications, the system might also be tuned to allow other transport and 
release mechanisms. For instance, the particles could also be moved with micromanipulators 
or microfluidic devices. For cellular uptake smaller particles could be used, and to target 
specific tissues in living organisms magnetic particles could replace the silica core. Release of 
molecules could also be assessed by alternative methods. Vesicles become leaky when heated 
through the phase transition temperature of their lipid mixture.[116] Thus, using specific lipid 
mixtures for the LUVs assembled on the LbL particles, would result in a temperature 
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sensitive system. The release in a defined biochemical environment is also possible. For 
instance, in the microenvironment of tumors the pH is reduced.[117] Liposomes that are 
sensitive for low pH values[50] could be used to release drugs at the tumor site. The 
combination of the maneuverable LbL particles with LUVs designed for the release of 
molecules under specific conditions would result in potential delivery systems for drugs. 
Moreover, the co-delivery of different substances could be achieved, e.g. of a pro-drug and an 
enzyme converting the pro-drug to the active substance at the desired place after release from 
the vesicles. 
Fusion of the vesicles assembled on the LbL particles was demonstrated: Using FRAP and 
FLIM measurements the mixing of the lipid bilayers upon addition of melittin was proven. 
The stability of liposomes and the abilty to trigger fusion in a controlled manner opens the 
way for application: Two reactants, or an enzyme and its substrate could be incorporated into 
the membranes of different LUVs. Fusion of the LUVs would result in the mixing of both 
compounds to start the reaction. 
LbL particles coated with several layers of vesicles are biomimetic structures. The vesicles 
represent lipid compartments or organelles able to store biomolecules, to retain specific 
chemical environments, and provide an enclosed place for distinct enzymatic reactions. By 
the combination of several vesicle-based reactors that work in tandem, complex micro 
factories can be constructed. The system is responsive to outer influences as it was 
demonstrated by the addition of melittin, and the different compartments can communicate 
with each other by mixing of molecules associated to membranes or entrapped inside the 
vesicles. Thus, the assembly of vesicles on LbL particles is not only a versatile approach that 
can find use as simple nanoreactor or drug delivery systems, it can also be a tool to simulate 
and study the complex interplay of cellular reaction pathways and to build networks of 
functional units reacting on remote control. 
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4.2 Lateral organization of lipophilic nucleic acids in lipid 
membranes 
 
Lateral inhomogeneous membranes can act as a template for a two dimensional sorting of 
membrane compounds. To this end, molecules have to be used that show a distinct 
partitioning behavior in membranes. A special attention should be drawn to the design of the 
membrane anchor that interacts with the lipids of different domains. As many molecules do 
not bind to lipid membranes they have to be connected to a lipophilic moiety to functionalize 
the membrane. Therefore, the domain targeting molecule is ideally addressable with a variety 
of functional molecules without changing the partitioning behavior, as it might be given for 
lipophilic nucleic acids. Thus, it would enable the domain specific functionalization of lipid 
domains on demand. 
Cholesteryl-TEG-modified DNA was incorporated into DOPC/SSM/Chol GUVs that show a 
liquid-liquid phase-separation. As it is known that the lo phase is enriched in cholesterol, it 
might be expected that the cholesteryl-TEG-based oligonucleotide also favorably partitions 
into this phase in DOPC/SSM/Chol GUVs. In fact, the construct partitioned equally into the 
lo and the ld phase, independent whether the construct was anchored via one or two 
cholesteryl-TEG moieties. Beales and Vanderlick revealed a 2:1 partitioning into the lo phase 
of oligonucleotides anchored with two cholesteryl-TEG moieties in the membrane of 
DOPC/DPPC/Chol GUVs. 2H and 31P NMR experiments showed that both the cholesteryl-
TEG anchor alone and the lipophilic oligonucleotides show a different behavior in lipid 
membranes compared to cholesterol.[118] When incorporated into POPC membranes 
cholesterol enhances the order of the lipid chains. For the cholesteryl-TEG anchor and the 
cholesterol-based oligonucleotides only minor effects were found. Therefore, it is reasonable 
to assume that the cholesterol anchor has a different orientation and insertion depth inside the 
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membrane compared to cholesterol resulting in a different phase partitioning behavior in the 
DOPC/SSM/Chol GUVs. 
Insertion and lateral partitioning of cholesterol-modified DNA in DOPC/POPS/SSM/Chol 
GUVs was also tested. At a low ionic strenght the charge of the oligonucleotides was not 
shielded by counterions, and the electrostatic repulsion prevented the lipophilic DNA from 
inserting into the lipid membrane. At a higher ionic strength the insertion was comparable to 
insertion into zwitterionic membranes. As the cholesterol-modified DNA is an amphiphilic 
molecule, lipophilic DNA already incorporated into the lipid membrane will presumably be 
extracted out of the membrane, when the ionic strength is reduced. When inserted into the 
lipid membrane, the cholesterol-modified oligonucleotides partitioned equally into both 
phases of DOPC/POPS/SSM/Chol GUVs. No influence of the negatively charged POPS on 
the lateral partitioning behavior of the negatively charged oligonucleotides was observed, 
although the POPS was enriched in one domain (ld). The negative charge of the 
oligonucleotides was shielded by counterions. The observation that the cholesterol-based 
DNA inserts into negatively charged, liquid-disordered membranes in presence of counterions 
has direct implications on biotechnological applications: It turned out, that a mixture of POPC 
and POPS (molar ratio: 1:1) is suited better than other lipid mixtures for a continuous and 
homogeneous covering of LbL particles enhancing their biocompatibility.[107] For a 
functionalization of these membrane-coated particles, lipophilic nucleic acids should be used, 
that insert into this membrane that is (i) highly negatively charged, and (ii) in a liquid-
disordered state. The cholesteryl-TEG-DNA presented in this work fulfills these criteria, and 
showed that it stably inserts into the lipid coated LbL particles (Figure 32).[118] 
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Figure 32: Membrane coated LbL particles, funtionalized with cholesterol-modified DNA. 
Taken from[118] 
 
FLIM measurements revealed FRET between the oligonucleotides labeled with a FRET donor 
(FAM) and the marker for the ld phase N-Rh-PE as a FRET acceptor. FRET efficiency was 
dependent on the used lipophilic oligonucleotide system. When the cholesterol-based DNA 
was anchored with one cholesterol moiety (chol_DNA1*), the energy transfer was higher 
compared to the anchoring with two cholesterol moieties (chol_DNA1*/chol_DNA2). This 
can be explained by the difference in the distance between FRET donor (FAM) and acceptor 
(Rh). Upon hybridization of chol_DNA1* and chol_DNA2 a stiff double helix was formed 
protruding away from the lipid bilayer as it was already reported.[23,119] In consequence, the 
distance between the FAM label on the oligonucleotide and N-Rh-PE inserted into the 
membrane was increased and FRET efficiency was reduced. In the presented work transfer 
efficiencies were used to correct the fluorescence intensities in the ld phase, for the 
calculation of the relative concentrations of cholesterol-based oligonucleotides in both lipid 
domains. Beyond that, the FLIM measurements revealed that the cholesterol-modified DNA, 
labeled with FAM, can be used as a sensor to detect target DNA complementary to the 
cholesterol-based DNA. 
Palmitoylated PNA was incorporated into the membranes of domain-forming GUVs, GPMVs 
and the plasma membrane of eukaryotic cells. It could be shown that this lipophilic PNA 
partitioned almost exclusively into the lo phase of DOPC/SSM/Chol GUVs and GPMVs 
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derived from CHO-K1 cells. These observations indicate that palmitoylated PNA possibly 
targets lipid rafts in eukayotic cells. Multiple palmitoylation drives rafts partitioning of many 
membrane proteins.[98] It is known that lipid rafts are involved in clathrin-independent 
endocytosis.[96] Thus, cellular uptake of the PNA or functional moieties linked via 
complementary DNA strands to PNA could be enhanced by using palmitoylated PNA. As 
PNA can bind with a high sensitivity for single base pair mismatches to single and double 
stranded DNA and RNA[14] it can be used for nucleic acid detection inside cells[120] and 
gene silencing.[14] These applications afford an efficient uptake into the cells, and 
palmitoylated PNA is a promising candidate to enhance the uptake. 
By incorporation of tocopherol modified DNA and palmitoylated PNA into liquid-liquid 
phase-separated GUVs and GPMVs Janus vesicles were built. Both constructs segregated 
almost exclusively to the different domains. Due to hybridization with complementary DNA 
or RNA the different domains can be functionalized on demand. In this way the ld and lo 
phase can be labeled with nucleic acids exhibiting specific recognition sites for ligands,[121] 
or proteins,[122] so-called aptamers. Furthermore, the domains can be equipped with nucleic 
acid based enzymes as DNAzymes or ribozymes,[123] or, using conjugates of DNA, with 
various fluorophores,[80] peptides,[80] or proteins.[82] This enables the building of 
micropatterned surfaces by the use of phase-separated membranes of GUVs, GPMVs or 
supported lipid membranes that can be functionalized with a plethora of functions. For 
instance, such a two dimensional organization can find application in lipid-based 
microarrays.[39]  
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Figure 33: Temperature controlled mixing and separation of lipophilic nucleic acids 
incorporated into phase-separated GUVs. 
 
Temperature controlled mixing and separation of the tocopherol based DNA and the 
palmitoylated PNA was also demonstrated (Figure 33). Upon heating over the phase 
transition temperature the lipid phases of the Janus vesicles vanished forming one ld phase, 
and both constructs were spread homogeneously over the whole membrane. When the 
temperature dropped again below the phase-separation temperature lipid domains were re-
formed and the lipophilic nucleic acids again segregated into different domains. The 
DNA/DNA and DNA/PNA hybrids did not melt upon heating, showing that the phase 
transition temperature was still below the melting temperatures of the duplexes: Mixing and 
separation of functional moieties attached to the complementary DNA strands was also 
achieved. The domain formation by cooling resembles in some way one of the underlying 
principles of the formation of lipid rafts: Here, nanoscaled assemblies of sphingolipids, 
cholesterol, and raft partitioning proteins are combined to functional platforms, e.g. by the 
oligomerization of raft proteins in response to external signals.[7] Thus, similar to the 
membranes of eukaryotic cells, specific functions can be induced by remote triggers, e.g. 
signaling cascades. Apart of this, domain mixing by heating leads to mixing of the molecules 
associated to the different phases and interactions between the molecules become possible. 
For instance, by attaching reactants to the complementary DNA, chemical reactions could be 
triggered. It is also possible to functionalize one domain with an enzyme and the other one 
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with its substrate. In this way temperature controlled microreactors can be fabricated. When 
the resulting product of the reaction can be detected, e.g. by its fluorescence, the Janus 
vesicles become temperature sensors. In conclusion, Janus vesicles, equipped with lipophilic 
nucleic acids are versatile tools for biotechnical applications, e.g microarrays, model systems 
for eukaryotic cell membranes, temperature sensitive microreactors, and sensors. 
Finally, both concepts – assembly of vesicles by DNA hybridization, and the domain specific 
partitioning of lipophilic nucleic acids – might be combined. Figure 34 illustrates how a 
directed vesicle assembly without a template could be achieved. First, complementary 
lipophilic nucleic acids that insert into the same domain could be incorporated into liquid-
liquid phase-separated vesicles (Figure 34a and b). This would presumably result in relatively 
small assemblies. Second, liquid-liquid phase-separated vesicles could be functionalized with 
complementary lipophilic oligonucloetides that partition into different domains (Figure 34c). 
In this way larger assemblies could be achieved where the domains of the vesicles are 
oriented in one direction. 
 
 
Figure 34: Assembly of liquid-liquid phase-separated vesicles using complementary 
lipophilic nucleic acids. When the lipophilic nucleic acids both partition into the lo (red) or 
the ld (green) phase, most likely small assemblies will be formed (a and b). When one 
lipophilic nucleic acid partitions into the lo and one into the ld domain, larger assemblies 
could be formed (c). Here, a directed orientation of the vesicles’ domains might be achieved.  
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Using lipid coated particles, GPMVs, or GUVs showing a phase-separation, the concept of 
the assembling of vesicles on a solid support could also be expanded. Different types of 
vesicles could be bound to different domains using for example palmitoylated PNA and 
tocopherol-based DNA as tethers for the lo and the ld phase, respectively (Figure 35). Thus, 
vesicles could also be laterally organized. 
 
 
Figure 35: Assembly of vesicles on lipid coated particles, GUVs, or GPMVs. A liquid-liquid 
phase-separated membrane provides a lateral sorting of the vesicles: Palmitoylated PNA, 
partitioning into the lo phase (rose), and tocopherol-modified DNA located to the ld phase 
(light green), tether different types of vesicles with incorporated complementary lipophilic 
nucleic acids (green, red) on different lipid domains. 
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5 Outlook 
 
Future prospects on vesicles assembled on LbL particles and the domain specific anchored 
lipophilic nucleic acids focus on biotechnological approaches. 
Vesicles assembled on LbL particles might serve as nanoreactors. For example, encapsulation 
of enzymes inside the assembled vesicles should be studied. Among many different methods 
to entrap active enzymes inside vesicles the dehydration-rehydration method with a 
subsequent extrusion step seems to be one of the most promising ones, as it ensures high 
encapsulation values.[51] By an external trigger the enzyme would be released to start a 
reaction with a substrate that is present outside the vesicles. More complex reactors with 
control over the reaction place can be constructed by encapsulation of both enzyme and 
substrate (or two reactants) separately into the vesicles assembled on the LbL particles 
(Figure 36). Fusion of the vesicles would lead to a content mixing and induce the reaction. 
The fusion of vesicles, however, is often accompanied by a transient leakage. Therefore, a 
method for an induced fusion without the loss of content should be applied for the mixing of 
the reactants or the enzyme/substrate system, e.g. a phospholipase C/sphingomyelinase 
triggered fusion.[124] Another way to avoid the loss of reactants could be the use of 
membrane associated reactants or enzyme/substrate pairs, that will not diffuse away when the 
lipid bilayers becomes leaky. An application for such nanoreactor systems could be the 
construction of delivery systems for prodrugs that are converted to the desired molecule just 
at the defined place. For this aim the product should be released from the vesicles after the 
reaction. When the membrane is permeable for the reaction product, it can escape from the 
lumen and reach its destiny. 
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Induced fusion 
of LUVs
Content mixing 
+ reaction
 
Figure 36: Scheme of two vesicles immobilized on a LbL particle by DNA hybridization. 
The vesicles are loaded with two reactants. Upon fusion of the vesicles, e.g. by the addition of 
melittin, the contents mix and a chemical reaction between the reactants starts resulting in the 
synthesis of a certain product (indicated as green stars). Alternatively, the vesicles can be 
loaded with an enzyme and its substrate. A release of the product will be obtained when the 
product can pass the membrane. 
 
For cholesterol-modified DNA and palmitoylated PNA the partitioning inside the plasma 
membrane of cells will be of great interest: Targeting to lipid rafts will have an impact on the 
uptake of the construct. In this way the efficient cellular delivery of nucleic acids, or any 
molecule attached to an oligonucleotide complementary to the lipohilic nucleic acid might be 
enabled. To investigate the lateral partitioning of membrane compounds inside cellular 
membranes, several methods have been developed, e.g. using FLIM,[6] or stimulated 
emission depletion microscopy (STED).[125] 
Finally, the partitioning behavior of lipophilic nucleic acids in phase-separated membranes 
can be tuned by a combination of different lipophilic anchors. Figure 37 shows a hybrid of a 
tocopherol-based oligonucleotide and palmitoylated PNA. As both constructs on their own 
partition into different lipid phases in liquid-liquid phase-separated lipid membranes, the 
partitioning behavior of lipophilic nucleic acids with one tocopherol and two palmitoyl 
anchors will be different for at least one of the constructs. By the cleavage of the dsDNA both 
lipophilic nucleic acids will again be separated resulting in a repartitioning of at least one of 
the lipophilic nucleic acids. Thus, it is possible to mimic the behavior of membrane proteins, 
whose partitioning behavior inside the cellular membrane into raft or non-raft regions is 
dependent on the modification with specific lipophilic moieties, to rebuild or study cellular 
processes like signaling pathways. 
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Figure 37: Hybrid of palmitoylated (dark grey) and tocopherol-based (black) nucleic acids, 
kept together by two DNA strands (black and light grey). A specific cleavage site allows 
separation of both lipophilic constructs that will result in a repartitioning of at least one of the 
lipophilic nucleic acids, when incorporated into the membrane of a liquid-liquid phase-
separated GUV. 
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